<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28663568</article-id>
<article-id pub-id-type="pmc">5491520</article-id>
<article-id pub-id-type="publisher-id">3054</article-id>
<article-id pub-id-type="doi">10.1038/s41598-017-03054-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Hendricks</surname>
<given-names>Audrey E.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Bochukova</surname>
<given-names>Elena G.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marenne</surname>
<given-names>Gaëlle</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keogh</surname>
<given-names>Julia M.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Atanassova</surname>
<given-names>Neli</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bounds</surname>
<given-names>Rebecca</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wheeler</surname>
<given-names>Eleanor</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mistry</surname>
<given-names>Vanisha</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Henning</surname>
<given-names>Elana</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Körner</surname>
<given-names>Antje</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muddyman</surname>
<given-names>Dawn</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCarthy</surname>
<given-names>Shane</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hinney</surname>
<given-names>Anke</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hebebrand</surname>
<given-names>Johannes</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scott</surname>
<given-names>Robert A.</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Langenberg</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wareham</surname>
<given-names>Nick J.</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Surendran</surname>
<given-names>Praveen</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Howson</surname>
<given-names>Joanna M.</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butterworth</surname>
<given-names>Adam S.</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Danesh</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nordestgaard</surname>
<given-names>Børge G</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nielsen</surname>
<given-names>Sune F</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Afzal</surname>
<given-names>Shoaib</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Papadia</surname>
<given-names>Sofia</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashford</surname>
<given-names>Sofie</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garg</surname>
<given-names>Sumedha</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Millhauser</surname>
<given-names>Glenn L.</given-names>
</name>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palomino</surname>
<given-names>Rafael I.</given-names>
</name>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kwasniewska</surname>
<given-names>Alexandra</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tachmazidou</surname>
<given-names>Ioanna</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Rahilly</surname>
<given-names>Stephen</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeggini</surname>
<given-names>Eleftheria</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Barroso</surname>
<given-names>Inês</given-names>
</name>
<address>
<email>ib1@sanger.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Farooqi</surname>
<given-names>I. Sadaf</given-names>
</name>
<address>
<email>isf20@cam.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<collab>Understanding Society Scientific Group<contrib-group><contrib contrib-type="author"><name><surname>Benzeval</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Burton</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Buck</surname><given-names>Nicholas</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Jäckle</surname><given-names>Annette</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Kumari</surname><given-names>Meena</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Laurie</surname><given-names>Heather</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Lynn</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Pudney</surname><given-names>Stephen</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Rabe</surname><given-names>Birgitta</given-names></name><xref ref-type="aff" rid="Aff14"></xref></contrib><contrib contrib-type="author"><name><surname>Wolke</surname><given-names>Dieter</given-names></name><xref ref-type="aff" rid="Aff15"></xref></contrib></contrib-group></collab>
</contrib>
<contrib contrib-type="author">
<collab>EPIC-CVD Consortium<contrib-group><contrib contrib-type="author"><name><surname>Overvad</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="Aff111"></xref><xref ref-type="aff" rid="Aff112"></xref></contrib><contrib contrib-type="author"><name><surname>Tjønneland</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="Aff113"></xref></contrib><contrib contrib-type="author"><name><surname>Clavel-Chapelon</surname><given-names>Francoise</given-names></name><xref ref-type="aff" rid="Aff114"></xref></contrib><contrib contrib-type="author"><name><surname>Kaaks</surname><given-names>Rudolf</given-names></name><xref ref-type="aff" rid="Aff115"></xref></contrib><contrib contrib-type="author"><name><surname>Boeing</surname><given-names>Heiner</given-names></name><xref ref-type="aff" rid="Aff116"></xref></contrib><contrib contrib-type="author"><name><surname>Trichopoulou</surname><given-names>Antonia</given-names></name><xref ref-type="aff" rid="Aff117"></xref><xref ref-type="aff" rid="Aff118"></xref></contrib><contrib contrib-type="author"><name><surname>Ferrari</surname><given-names>Pietro</given-names></name><xref ref-type="aff" rid="Aff119"></xref></contrib><contrib contrib-type="author"><name><surname>Palli</surname><given-names>Domenico</given-names></name><xref ref-type="aff" rid="Aff120"></xref></contrib><contrib contrib-type="author"><name><surname>Krogha</surname><given-names>Vittorio</given-names></name><xref ref-type="aff" rid="Aff121"></xref></contrib><contrib contrib-type="author"><name><surname>Panico</surname><given-names>Salvatore</given-names></name><xref ref-type="aff" rid="Aff122"></xref></contrib><contrib contrib-type="author"><name><surname>Tuminoa</surname><given-names>Rosario</given-names></name><xref ref-type="aff" rid="Aff123"></xref></contrib><contrib contrib-type="author"><name><surname>Matullo</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="Aff124"></xref><xref ref-type="aff" rid="Aff125"></xref></contrib><contrib contrib-type="author"><name><surname>Boer</surname><given-names>Jolanda</given-names></name><xref ref-type="aff" rid="Aff126"></xref></contrib><contrib contrib-type="author"><name><surname>van. der. Schouw</surname><given-names>Yvonne</given-names></name><xref ref-type="aff" rid="Aff127"></xref></contrib><contrib contrib-type="author"><name><surname>Weiderpass</surname><given-names>Elisabete</given-names></name><xref ref-type="aff" rid="Aff128"></xref><xref ref-type="aff" rid="Aff129"></xref><xref ref-type="aff" rid="Aff130"></xref><xref ref-type="aff" rid="Aff131"></xref></contrib><contrib contrib-type="author"><name><surname>Quiros</surname><given-names>J. Ramon</given-names></name><xref ref-type="aff" rid="Aff132"></xref></contrib><contrib contrib-type="author"><name><surname>Sánchez</surname><given-names>María-José</given-names></name><xref ref-type="aff" rid="Aff133"></xref><xref ref-type="aff" rid="Aff134"></xref></contrib><contrib contrib-type="author"><name><surname>Navarro</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="Aff135"></xref><xref ref-type="aff" rid="Aff136"></xref></contrib><contrib contrib-type="author"><name><surname>Moreno-Iribas</surname><given-names>Conchi</given-names></name><xref ref-type="aff" rid="Aff113"></xref><xref ref-type="aff" rid="Aff134"></xref></contrib><contrib contrib-type="author"><name><surname>Arriola</surname><given-names>Larraitz</given-names></name><xref ref-type="aff" rid="Aff137"></xref></contrib><contrib contrib-type="author"><name><surname>Melander</surname><given-names>Olle</given-names></name><xref ref-type="aff" rid="Aff138"></xref></contrib><contrib contrib-type="author"><name><surname>Wennberg</surname><given-names>Patrik</given-names></name><xref ref-type="aff" rid="Aff139"></xref></contrib><contrib contrib-type="author"><name><surname>Key</surname><given-names>Timothy J.</given-names></name><xref ref-type="aff" rid="Aff140"></xref></contrib><contrib contrib-type="author"><name><surname>Riboli</surname><given-names>Elio</given-names></name><xref ref-type="aff" rid="Aff141"></xref></contrib></contrib-group></collab>
</contrib>
<contrib contrib-type="author">
<collab>UK10K Consortium<contrib-group><contrib contrib-type="author"><name><surname>Turki</surname><given-names>Saeed Al</given-names></name><xref ref-type="aff" rid="Aff16"></xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Carl A.</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Anney</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="Aff17"></xref></contrib><contrib contrib-type="author"><name><surname>Antony</surname><given-names>Dinu</given-names></name><xref ref-type="aff" rid="Aff18"></xref></contrib><contrib contrib-type="author"><name><surname>Soler Artigas</surname><given-names>María</given-names></name><xref ref-type="aff" rid="Aff19"></xref></contrib><contrib contrib-type="author"><name><surname>Ayub</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="Aff20"></xref></contrib><contrib contrib-type="author"><name><surname>Bala</surname><given-names>Senduran</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Barrett</surname><given-names>Jeffrey C.</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Beales</surname><given-names>Phil</given-names></name><xref ref-type="aff" rid="Aff18"></xref></contrib><contrib contrib-type="author"><name><surname>Bentham</surname><given-names>Jamie</given-names></name><xref ref-type="aff" rid="Aff21"></xref></contrib><contrib contrib-type="author"><name><surname>Bhattacharyaa</surname><given-names>Shoumo</given-names></name><xref ref-type="aff" rid="Aff21"></xref></contrib><contrib contrib-type="author"><name><surname>Birney</surname><given-names>Ewan</given-names></name><xref ref-type="aff" rid="Aff22"></xref></contrib><contrib contrib-type="author"><name><surname>Blackwooda</surname><given-names>Douglas</given-names></name><xref ref-type="aff" rid="Aff23"></xref></contrib><contrib contrib-type="author"><name><surname>Bobrow</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff24"></xref></contrib><contrib contrib-type="author"><name><surname>Bolton</surname><given-names>Patrick F.</given-names></name><xref ref-type="aff" rid="Aff25"></xref><xref ref-type="aff" rid="Aff26"></xref><xref ref-type="aff" rid="Aff27"></xref></contrib><contrib contrib-type="author"><name><surname>Boustred</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="Aff28"></xref></contrib><contrib contrib-type="author"><name><surname>Breen</surname><given-names>Gerome</given-names></name><xref ref-type="aff" rid="Aff26"></xref><xref ref-type="aff" rid="Aff27"></xref></contrib><contrib contrib-type="author"><name><surname>Calissanoa</surname><given-names>Mattia</given-names></name><xref ref-type="aff" rid="Aff129"></xref></contrib><contrib contrib-type="author"><name><surname>Carss</surname><given-names>Keren</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Charlton</surname><given-names>Ruth</given-names></name><xref ref-type="aff" rid="Aff30"></xref></contrib><contrib contrib-type="author"><name><surname>Chatterjee</surname><given-names>Krishna</given-names></name><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="Aff31"></xref></contrib><contrib contrib-type="author"><name><surname>Ciampia</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="Aff32"></xref></contrib><contrib contrib-type="author"><name><surname>Cirak</surname><given-names>Sebahattin</given-names></name><xref ref-type="aff" rid="Aff29"></xref><xref ref-type="aff" rid="Aff33"></xref></contrib><contrib contrib-type="author"><name><surname>Clapham</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Clement</surname><given-names>Gail</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Coates</surname><given-names>Guy</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Coccaa</surname><given-names>Massimiliano</given-names></name><xref ref-type="aff" rid="Aff35"></xref><xref ref-type="aff" rid="Aff36"></xref></contrib><contrib contrib-type="author"><name><surname>Collier</surname><given-names>David A.</given-names></name><xref ref-type="aff" rid="Aff27"></xref><xref ref-type="aff" rid="Aff37"></xref></contrib><contrib contrib-type="author"><name><surname>Cosgrove</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="Aff21"></xref></contrib><contrib contrib-type="author"><name><surname>Coxa</surname><given-names>Tony</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Craddock</surname><given-names>Nick</given-names></name><xref ref-type="aff" rid="Aff38"></xref></contrib><contrib contrib-type="author"><name><surname>Crooks</surname><given-names>Lucy</given-names></name><xref ref-type="aff" rid="Aff39"></xref></contrib><contrib contrib-type="author"><name><surname>Curran</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="Aff25"></xref><xref ref-type="aff" rid="Aff40"></xref><xref ref-type="aff" rid="Aff41"></xref></contrib><contrib contrib-type="author"><name><surname>Curtis</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff42"></xref></contrib><contrib contrib-type="author"><name><surname>Daly</surname><given-names>Allan</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Danecek</surname><given-names>Petr</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Day</surname><given-names>Ian N. M.</given-names></name><xref ref-type="aff" rid="Aff43"></xref></contrib><contrib contrib-type="author"><name><surname>Day-Williams</surname><given-names>Aaron</given-names></name><xref ref-type="aff" rid="Aff44"></xref></contrib><contrib contrib-type="author"><name><surname>Dominiczak</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff45"></xref></contrib><contrib contrib-type="author"><name><surname>Down</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff46"></xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Yuanping</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Dunham</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="Aff22"></xref></contrib><contrib contrib-type="author"><name><surname>Durbin</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Edkins</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ekong</surname><given-names>Rosemary</given-names></name><xref ref-type="aff" rid="Aff48"></xref></contrib><contrib contrib-type="author"><name><surname>Ellis</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Evansa</surname><given-names>David M.</given-names></name><xref ref-type="aff" rid="Aff49"></xref><xref ref-type="aff" rid="Aff50"></xref></contrib><contrib contrib-type="author"><name><surname>Fitzpatrick</surname><given-names>David R.</given-names></name><xref ref-type="aff" rid="Aff51"></xref></contrib><contrib contrib-type="author"><name><surname>Flicek</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff22"></xref></contrib><contrib contrib-type="author"><name><surname>Floyd</surname><given-names>James</given-names></name><xref ref-type="aff" rid="Aff52"></xref></contrib><contrib contrib-type="author"><name><surname>Foley</surname><given-names>A. Reghan</given-names></name><xref ref-type="aff" rid="Aff29"></xref></contrib><contrib contrib-type="author"><name><surname>Franklin</surname><given-names>Christopher S.</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Futema</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="Aff53"></xref></contrib><contrib contrib-type="author"><name><surname>Gallagher</surname><given-names>Louise</given-names></name><xref ref-type="aff" rid="Aff17"></xref></contrib><contrib contrib-type="author"><name><surname>Gaunt</surname><given-names>Tom R.</given-names></name><xref ref-type="aff" rid="Aff49"></xref></contrib><contrib contrib-type="author"><name><surname>Geihs</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Geschwind</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="Aff54"></xref></contrib><contrib contrib-type="author"><name><surname>Greenwood</surname><given-names>Celia M. T.</given-names></name><xref ref-type="aff" rid="Aff32"></xref><xref ref-type="aff" rid="Aff55"></xref><xref ref-type="aff" rid="Aff56"></xref><xref ref-type="aff" rid="Aff57"></xref></contrib><contrib contrib-type="author"><name><surname>Griffin</surname><given-names>Heather</given-names></name><xref ref-type="aff" rid="Aff58"></xref></contrib><contrib contrib-type="author"><name><surname>Grozeva</surname><given-names>Detelina</given-names></name><xref ref-type="aff" rid="Aff24"></xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Xiaosen</given-names></name><xref ref-type="aff" rid="Aff47"></xref><xref ref-type="aff" rid="Aff59"></xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Xueqin</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Gurling</surname><given-names>Hugh</given-names></name><xref ref-type="aff" rid="Aff60"></xref></contrib><contrib contrib-type="author"><name><surname>Hart</surname><given-names>Deborah</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Holmans</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff38"></xref></contrib><contrib contrib-type="author"><name><surname>Howie</surname><given-names>Bryan</given-names></name><xref ref-type="aff" rid="Aff61"></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Liren</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Hubbard</surname><given-names>Tim</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff46"></xref></contrib><contrib contrib-type="author"><name><surname>Humphries</surname><given-names>Steve E.</given-names></name><xref ref-type="aff" rid="Aff53"></xref></contrib><contrib contrib-type="author"><name><surname>Hurles</surname><given-names>Matthew E.</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Hysi</surname><given-names>Pirro</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Iotchkova</surname><given-names>Valentina</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff22"></xref></contrib><contrib contrib-type="author"><name><surname>Jackson</surname><given-names>David K.</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Jamshidi</surname><given-names>Yalda</given-names></name><xref ref-type="aff" rid="Aff62"></xref></contrib><contrib contrib-type="author"><name><surname>Joyce</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Karczewski</surname><given-names>Konrad J.</given-names></name><xref ref-type="aff" rid="Aff3"></xref><xref ref-type="aff" rid="Aff6"></xref><xref ref-type="aff" rid="Aff4"></xref></contrib><contrib contrib-type="author"><name><surname>Kaye</surname><given-names>Jane</given-names></name><xref ref-type="aff" rid="Aff8"></xref></contrib><contrib contrib-type="author"><name><surname>Keane</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Kemp</surname><given-names>John P.</given-names></name><xref ref-type="aff" rid="Aff49"></xref><xref ref-type="aff" rid="Aff50"></xref></contrib><contrib contrib-type="author"><name><surname>Kennedy</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff65"></xref></contrib><contrib contrib-type="author"><name><surname>Kent</surname><given-names>Alastair</given-names></name><xref ref-type="aff" rid="Aff66"></xref></contrib><contrib contrib-type="author"><name><surname>Khawaja</surname><given-names>Farrah</given-names></name><xref ref-type="aff" rid="Aff67"></xref></contrib><contrib contrib-type="author"><name><surname>van Kogelenberg</surname><given-names>Margriet</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Kolb-Kokocinski</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Lachance</surname><given-names>Genevieve</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Langford</surname><given-names>Cordelia</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Lawson</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="Aff68"></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Irene</given-names></name><xref ref-type="aff" rid="Aff69"></xref></contrib><contrib contrib-type="author"><name><surname>Lek</surname><given-names>Monkol</given-names></name><xref ref-type="aff" rid="Aff63"></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="Aff55"></xref><xref ref-type="aff" rid="Aff56"></xref><xref ref-type="aff" rid="Aff70"></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yingrui</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Jieqin</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ryan</given-names></name><xref ref-type="aff" rid="Aff71"></xref></contrib><contrib contrib-type="author"><name><surname>Lönnqvist</surname><given-names>Jouko</given-names></name><xref ref-type="aff" rid="Aff72"></xref></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Luis R.</given-names></name><xref ref-type="aff" rid="Aff73"></xref><xref ref-type="aff" rid="Aff74"></xref></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Margarida</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff75"></xref><xref ref-type="aff" rid="Aff76"></xref></contrib><contrib contrib-type="author"><name><surname>MacArthur</surname><given-names>Daniel G.</given-names></name><xref ref-type="aff" rid="Aff63"></xref><xref ref-type="aff" rid="Aff64"></xref></contrib><contrib contrib-type="author"><name><surname>Mangino</surname><given-names>Massimo</given-names></name><xref ref-type="aff" rid="Aff34"></xref><xref ref-type="aff" rid="Aff77"></xref></contrib><contrib contrib-type="author"><name><surname>Marchini</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="Aff75"></xref><xref ref-type="aff" rid="Aff78"></xref></contrib><contrib contrib-type="author"><name><surname>Maslen</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Mathieson</surname><given-names>Iain</given-names></name><xref ref-type="aff" rid="Aff79"></xref></contrib><contrib contrib-type="author"><name><surname>McGuffin</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff27"></xref></contrib><contrib contrib-type="author"><name><surname>McIntosh</surname><given-names>Andrew M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McKechanie</surname><given-names>Andrew G.</given-names></name><xref ref-type="aff" rid="Aff23"></xref><xref ref-type="aff" rid="Aff80"></xref></contrib><contrib contrib-type="author"><name><surname>McQuillin</surname><given-names>Andrew</given-names></name></contrib><contrib contrib-type="author"><name><surname>Memari</surname><given-names>Yasin</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Metrustry</surname><given-names>Sarah</given-names></name></contrib><contrib contrib-type="author"><name><surname>Migone</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="Aff81"></xref></contrib><contrib contrib-type="author"><name><surname>Min</surname><given-names>Josine L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mitchison</surname><given-names>Hannah M.</given-names></name><xref ref-type="aff" rid="Aff18"></xref></contrib><contrib contrib-type="author"><name><surname>Moayyeri</surname><given-names>Alireza</given-names></name><xref ref-type="aff" rid="Aff34"></xref><xref ref-type="aff" rid="Aff52"></xref></contrib><contrib contrib-type="author"><name><surname>Morris</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="Aff82"></xref><xref ref-type="aff" rid="Aff83"></xref></contrib><contrib contrib-type="author"><name><surname>Morris</surname><given-names>James</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Muntoni</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="Aff29"></xref></contrib><contrib contrib-type="author"><name><surname>Northstone</surname><given-names>Kate</given-names></name></contrib><contrib contrib-type="author"><name><surname>O’Donovan</surname><given-names>Michael C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Onoufriadis</surname><given-names>Alexandros</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oualkacha</surname><given-names>Karim</given-names></name><xref ref-type="aff" rid="Aff84"></xref></contrib><contrib contrib-type="author"><name><surname>Owen</surname><given-names>Michael J.</given-names></name><xref ref-type="aff" rid="Aff38"></xref></contrib><contrib contrib-type="author"><name><surname>Palotie</surname><given-names>Aarno</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff85"></xref><xref ref-type="aff" rid="Aff86"></xref></contrib><contrib contrib-type="author"><name><surname>Panoutsopoulou</surname><given-names>Kalliope</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Parker</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author"><name><surname>Parr</surname><given-names>Jeremy R.</given-names></name><xref ref-type="aff" rid="Aff87"></xref></contrib><contrib contrib-type="author"><name><surname>Paternoster</surname><given-names>Lavinia</given-names></name><xref ref-type="aff" rid="Aff49"></xref></contrib><contrib contrib-type="author"><name><surname>Paunio</surname><given-names>Tiina</given-names></name><xref ref-type="aff" rid="Aff72"></xref><xref ref-type="aff" rid="Aff88"></xref></contrib><contrib contrib-type="author"><name><surname>Payne</surname><given-names>Felicity</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Payne</surname><given-names>Stewart J.</given-names></name><xref ref-type="aff" rid="Aff89"></xref></contrib><contrib contrib-type="author"><name><surname>Perry</surname><given-names>John R. B.</given-names></name><xref ref-type="aff" rid="Aff8"></xref><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Pietilainen</surname><given-names>Olli</given-names></name><xref ref-type="aff" rid="Aff72"></xref><xref ref-type="aff" rid="Aff85"></xref></contrib><contrib contrib-type="author"><name><surname>Plagnol</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="Aff90"></xref></contrib><contrib contrib-type="author"><name><surname>Pollitt</surname><given-names>Rebecca C.</given-names></name><xref ref-type="aff" rid="Aff91"></xref></contrib><contrib contrib-type="author"><name><surname>Porteous</surname><given-names>David J.</given-names></name><xref ref-type="aff" rid="Aff92"></xref></contrib><contrib contrib-type="author"><name><surname>Povey</surname><given-names>Sue</given-names></name><xref ref-type="aff" rid="Aff48"></xref></contrib><contrib contrib-type="author"><name><surname>Quail</surname><given-names>Michael A.</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Quaye</surname><given-names>Lydia</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Raymond</surname><given-names>F. Lucy</given-names></name><xref ref-type="aff" rid="Aff24"></xref></contrib><contrib contrib-type="author"><name><surname>Rehnström</surname><given-names>Karola</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Richards</surname><given-names>J. Brent</given-names></name><xref ref-type="aff" rid="Aff32"></xref><xref ref-type="aff" rid="Aff34"></xref><xref ref-type="aff" rid="Aff55"></xref><xref ref-type="aff" rid="Aff56"></xref><xref ref-type="aff" rid="Aff70"></xref></contrib><contrib contrib-type="author"><name><surname>Ridout</surname><given-names>Cheryl K.</given-names></name><xref ref-type="aff" rid="Aff93"></xref></contrib><contrib contrib-type="author"><name><surname>Ring</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="Aff94"></xref></contrib><contrib contrib-type="author"><name><surname>Ritchie</surname><given-names>Graham R. S.</given-names></name><xref ref-type="aff" rid="Aff22"></xref></contrib><contrib contrib-type="author"><name><surname>Roberts</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="Aff124"></xref></contrib><contrib contrib-type="author"><name><surname>Robinson</surname><given-names>Rachel L.</given-names></name><xref ref-type="aff" rid="Aff30"></xref></contrib><contrib contrib-type="author"><name><surname>Savage</surname><given-names>David B.</given-names></name><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author"><name><surname>Scambler</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff18"></xref></contrib><contrib contrib-type="author"><name><surname>Schiffels</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Schmidts</surname><given-names>Miriam</given-names></name><xref ref-type="aff" rid="Aff18"></xref><xref ref-type="aff" rid="Aff95"></xref></contrib><contrib contrib-type="author"><name><surname>Schoenmakers</surname><given-names>Nadia</given-names></name><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Richard H.</given-names></name><xref ref-type="aff" rid="Aff18"></xref><xref ref-type="aff" rid="Aff96"></xref></contrib><contrib contrib-type="author"><name><surname>Semple</surname><given-names>Robert K.</given-names></name><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author"><name><surname>Serra</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Sharp</surname><given-names>Sally I.</given-names></name><xref ref-type="aff" rid="Aff60"></xref></contrib><contrib contrib-type="author"><name><surname>Shaw</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="Aff97"></xref></contrib><contrib contrib-type="author"><name><surname>Shihab</surname><given-names>Hashem A.</given-names></name><xref ref-type="aff" rid="Aff49"></xref></contrib><contrib contrib-type="author"><name><surname>Shin</surname><given-names>So-Youn</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff49"></xref></contrib><contrib contrib-type="author"><name><surname>Skuse</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff69"></xref></contrib><contrib contrib-type="author"><name><surname>Small</surname><given-names>Kerrin S.</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Smee</surname><given-names>Carol</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Blair H.</given-names></name><xref ref-type="aff" rid="Aff98"></xref></contrib><contrib contrib-type="author"><name><surname>Davey Smith</surname><given-names>George</given-names></name><xref ref-type="aff" rid="Aff49"></xref></contrib><contrib contrib-type="author"><name><surname>Soranzo</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff31"></xref></contrib><contrib contrib-type="author"><name><surname>Southam</surname><given-names>Lorraine</given-names></name><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff75"></xref></contrib><contrib contrib-type="author"><name><surname>Spasic-Boskovic</surname><given-names>Olivera</given-names></name><xref ref-type="aff" rid="Aff24"></xref></contrib><contrib contrib-type="author"><name><surname>Spector</surname><given-names>Timothy D.</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>St Clair</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff99"></xref></contrib><contrib contrib-type="author"><name><surname>St Pourcain</surname><given-names>Beate</given-names></name><xref ref-type="aff" rid="Aff49"></xref><xref ref-type="aff" rid="Aff100"></xref><xref ref-type="aff" rid="Aff101"></xref></contrib><contrib contrib-type="author"><name><surname>Stalker</surname><given-names>Jim</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Stevens</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="Aff29"></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Jianping</given-names></name><xref ref-type="aff" rid="Aff32"></xref><xref ref-type="aff" rid="Aff55"></xref></contrib><contrib contrib-type="author"><name><surname>Surdulescu</surname><given-names>Gabriela</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Suvisaari</surname><given-names>Jaana</given-names></name><xref ref-type="aff" rid="Aff72"></xref></contrib><contrib contrib-type="author"><name><surname>Syrris</surname><given-names>Petros</given-names></name><xref ref-type="aff" rid="Aff73"></xref></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>Rohan</given-names></name><xref ref-type="aff" rid="Aff67"></xref></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Timpson</surname><given-names>Nicholas J.</given-names></name><xref ref-type="aff" rid="Aff49"></xref></contrib><contrib contrib-type="author"><name><surname>Tobin</surname><given-names>Martin D.</given-names></name><xref ref-type="aff" rid="Aff19"></xref><xref ref-type="aff" rid="Aff102"></xref></contrib><contrib contrib-type="author"><name><surname>Valdes</surname><given-names>Ana M.</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Vandersteen</surname><given-names>Anthony M.</given-names></name><xref ref-type="aff" rid="Aff103"></xref></contrib><contrib contrib-type="author"><name><surname>Vijayarangakannan</surname><given-names>Parthiban</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Visscher</surname><given-names>Peter M.</given-names></name><xref ref-type="aff" rid="Aff50"></xref><xref ref-type="aff" rid="Aff104"></xref></contrib><contrib contrib-type="author"><name><surname>Wain</surname><given-names>Louise V.</given-names></name><xref ref-type="aff" rid="Aff19"></xref></contrib><contrib contrib-type="author"><name><surname>Walter</surname><given-names>Klaudia</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Walters</surname><given-names>James T. R.</given-names></name><xref ref-type="aff" rid="Aff38"></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Guangbiao</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="Aff47"></xref><xref ref-type="aff" rid="Aff59"></xref><xref ref-type="aff" rid="Aff105"></xref><xref ref-type="aff" rid="Aff106"></xref><xref ref-type="aff" rid="Aff107"></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Ward</surname><given-names>Kirsten</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Whyte</surname><given-names>Tamieka</given-names></name><xref ref-type="aff" rid="Aff29"></xref></contrib><contrib contrib-type="author"><name><surname>Williams</surname><given-names>Hywel J.</given-names></name><xref ref-type="aff" rid="Aff38"></xref><xref ref-type="aff" rid="Aff108"></xref></contrib><contrib contrib-type="author"><name><surname>Williamson</surname><given-names>Kathleen A.</given-names></name><xref ref-type="aff" rid="Aff51"></xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Crispian</given-names></name><xref ref-type="aff" rid="Aff24"></xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Scott G.</given-names></name><xref ref-type="aff" rid="Aff24"></xref><xref ref-type="aff" rid="Aff109"></xref><xref ref-type="aff" rid="Aff110"></xref></contrib><contrib contrib-type="author"><name><surname>Wong</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>ChangJiang</given-names></name><xref ref-type="aff" rid="Aff32"></xref><xref ref-type="aff" rid="Aff55"></xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="Aff50"></xref><xref ref-type="aff" rid="Aff104"></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="Aff34"></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Pingbo</given-names></name><xref ref-type="aff" rid="Aff47"></xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name><xref ref-type="aff" rid="Aff55"></xref><xref ref-type="aff" rid="Aff56"></xref><xref ref-type="aff" rid="Aff70"></xref></contrib></contrib-group></collab>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0606 5382</institution-id><institution-id institution-id-type="GRID">grid.10306.34</institution-id><institution></institution><institution>Wellcome Trust Sanger Institute, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000107903411</institution-id><institution-id institution-id-type="GRID">grid.241116.1</institution-id><institution>Department of Mathematical and Statistical Sciences, </institution><institution>University of Colorado-Denver, </institution></institution-wrap>Denver, CO 80204 USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0622 5016</institution-id><institution-id institution-id-type="GRID">grid.120073.7</institution-id><institution></institution><institution>University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke’s Hospital, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution>The Blizard Institute, Barts and The London School of Medicine and Dentistry, </institution><institution>Queen Mary University of London, </institution></institution-wrap>London, UK </aff>
<aff id="Aff5"><label>5</label>Center for Pediatric Research, University Children’s Hospital Leipzig, Leipzig, Germany </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2230 9752</institution-id><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution>IFB Adiposity Diseases Medical Faculty, </institution><institution>University of Leipzig, </institution></institution-wrap>Leipzig, Germany </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0262 7331</institution-id><institution-id institution-id-type="GRID">grid.410718.b</institution-id><institution>Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, </institution><institution>University Hospital Essen and University of Duisburg-Essen, </institution></institution-wrap>Essen, Germany </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>MRC Epidemiology Unit, Institute of Metabolic Science, </institution><institution>University of Cambridge School of Clinical Medicine, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, </institution><institution>University of Cambridge, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>The National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics, </institution><institution>University of Cambridge, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff11"><label>11</label>Department of Clinical Biochemistry and The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark </aff>
<aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution>Faculty of Health and Medical Sciences, </institution><institution>University of Copenhagen, </institution></institution-wrap>Copenhagen, Denmark </aff>
<aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution>Department of Chemistry &amp; Biochemistry, </institution><institution>University of California Santa Cruz, </institution></institution-wrap>Santa Cruz, CA 95064 USA </aff>
<aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0942 6946</institution-id><institution-id institution-id-type="GRID">grid.8356.8</institution-id><institution>Institute for Social and Economic Research, </institution><institution>University of Essex, </institution></institution-wrap>Colchester, UK </aff>
<aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8809 1613</institution-id><institution-id institution-id-type="GRID">grid.7372.1</institution-id><institution></institution><institution>University of Warwick, </institution></institution-wrap>Warwick, UK </aff>
<aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1790 7311</institution-id><institution-id institution-id-type="GRID">grid.415254.3</institution-id><institution>Department of Pathology, </institution><institution>King Abdulaziz Medical City, </institution></institution-wrap>P.O. Box 22490, Riyadh, 11426 Saudi Arabia </aff>
<aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0617 8280</institution-id><institution-id institution-id-type="GRID">grid.416409.e</institution-id><institution>Department of Psychiatry, </institution><institution>Trinity Centre for Health Sciences, St James Hospital, </institution></institution-wrap>James’s Street, Dublin, 8 Ireland </aff>
<aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>Genetics and Genomic Medicine and Birth Defects Research Centre, </institution><institution>UCL Institute of Child Health, </institution></institution-wrap>London, WC1N 1EH UK </aff>
<aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8411</institution-id><institution-id institution-id-type="GRID">grid.9918.9</institution-id><institution>Departments of Health Sciences and Genetics, </institution><institution>University of Leicester, </institution></institution-wrap>Leicester, LE1 7RH UK </aff>
<aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8331</institution-id><institution-id institution-id-type="GRID">grid.410356.5</institution-id><institution>Division of Developmental Disabilities, Department of Psychiatry, </institution><institution>Queen’s University, </institution></institution-wrap>Kingston, Ontario, N6C 0A7 Canada </aff>
<aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution></institution><institution>Department of Cardiovascular Medicine and Wellcome Trust Centre for Human Genetics, </institution></institution-wrap>Roosevelt Drive, Oxford, OX3 7BN UK </aff>
<aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9709 7726</institution-id><institution-id institution-id-type="GRID">grid.225360.0</institution-id><institution>European Molecular Biology Laboratory, </institution><institution>European Bioinformatics Institute, </institution></institution-wrap>Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD UK </aff>
<aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution>Division of Psychiatry, </institution><institution>The University of Edinburgh, Royal Edinburgh Hospital, </institution></institution-wrap>Edinburgh, EH10 5HF UK </aff>
<aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0622 5016</institution-id><institution-id institution-id-type="GRID">grid.120073.7</institution-id><institution>Academic Laboratory of Medical Genetics, </institution><institution>Box 238, Lv 6 Addenbrooke’s Treatment Centre, Addenbrooke’s Hospital, </institution></institution-wrap>Cambridge, CB2 0QQ UK </aff>
<aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution>Department of Child Psychiatry, </institution><institution>Institute of Psychiatry, Psychology and Neuroscience, King’s College London, </institution></institution-wrap>16 De Crespigny Park, London, SE5 8AF UK </aff>
<aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution>NIHR BRC for Mental Health, </institution><institution>Institute of Psychiatry, Psychology and Neuroscience and SLaM NHS Trust, King’s College London, London, UK. 16 De Crespigny Park, </institution></institution-wrap>London, SE5 8AF UK </aff>
<aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution>MRC Social, Genetic and Developmental Psychiatry Centre, </institution><institution>Institute of Psychiatry, Psychology and Neuroscience, King’s College London, </institution></institution-wrap>Denmark Hill, London, SE5 8AF UK </aff>
<aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.420468.c</institution-id><institution>North East Thames Regional Genetics Service, </institution><institution>Great Ormond Street Hospital NHS Foundation Trust, </institution></institution-wrap>London, WC1N 3JH UK </aff>
<aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>Dubowitz Neuromuscular Centre, </institution><institution>UCL Institute of Child Health &amp; Great Ormond Street Hospital, </institution></institution-wrap>London, WC1N 1EH UK </aff>
<aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.443984.6</institution-id><institution>Leeds Genetics Laboratory, </institution><institution>St James University Hospital, </institution></institution-wrap>Beckett Street, Leeds, LS9 7TF UK </aff>
<aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>Department of Haematology, </institution><institution>University of Cambridge, </institution></institution-wrap>Long Road, Cambridge, CB2 0PT UK </aff>
<aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution>Department of Epidemiology, </institution><institution>Biostatistics and Occupational Health, McGill University, </institution></institution-wrap>Montreal, Quebec, H3A 1A2 Canada </aff>
<aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8852 305X</institution-id><institution-id institution-id-type="GRID">grid.411097.a</institution-id><institution>Institut für Humangenetik, </institution><institution>Uniklinik Köln, </institution></institution-wrap>Kerpener Strasse 34, 50931 Köln, Germany </aff>
<aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution>The Department of Twin Research &amp; Genetic Epidemiology, </institution><institution>King’s College London, </institution></institution-wrap>St Thomas’ Campus, Lambeth Palace Road, London, SE1 7EH UK </aff>
<aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1760 7415</institution-id><institution-id institution-id-type="GRID">grid.418712.9</institution-id><institution>Medical Genetics, </institution><institution>Institute for Maternal and Child Health IRCCS “Burlo Garofolo”, </institution></institution-wrap>34100 Trieste, Italy </aff>
<aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1941 4308</institution-id><institution-id institution-id-type="GRID">grid.5133.4</institution-id><institution>Department of Medical, </institution><institution>Surgical and Health Sciences, University of Trieste, </institution></institution-wrap>34100 Trieste, Italy </aff>
<aff id="Aff37"><label>37</label>Lilly Research Laboratories, Eli Lilly &amp; Co. Ltd., Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH UK </aff>
<aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0807 5670</institution-id><institution-id institution-id-type="GRID">grid.5600.3</institution-id><institution>MRC Centre for Neuropsychiatric Genetics &amp; Genomics, </institution><institution>Institute of Psychological Medicine &amp; Clinical Neurosciences, School of Medicine, Cardiff University, </institution></institution-wrap>Cardiff, CF24 4HQ UK </aff>
<aff id="Aff39"><label>39</label>Sheffield Diagnostic Genetics Service, Sheffield Childrens’ NHS Foundation Trust, Western Bank, Sheffield, S10 2TH UK </aff>
<aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7590</institution-id><institution-id institution-id-type="GRID">grid.12082.39</institution-id><institution></institution><institution>University of Sussex, </institution></institution-wrap>Brighton, BN1 9RH UK </aff>
<aff id="Aff41"><label>41</label>Sussex Partnership NHS Foundation Trust, Swandean, Arundel Road, Worthing, BN13 3EP UK </aff>
<aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution></institution><institution>University College London (UCL), UCL Genetics Institute, Darwin Building, </institution></institution-wrap>Gower Street, London, WC1E 6BT UK </aff>
<aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution>Bristol Genetic Epidemiology Laboratories, </institution><institution>School of Social and Community Medicine, University of Bristol, Oakfield House, </institution></institution-wrap>Oakfield Grove, Clifton, Bristol BS8 2BN UK </aff>
<aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0384 8146</institution-id><institution-id institution-id-type="GRID">grid.417832.b</institution-id><institution>Computational Biology &amp; Genomics, </institution><institution>Biogen Idec, 14 Cambridge Center, </institution></institution-wrap>Cambridge, Massachusetts 02142 USA </aff>
<aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2193 314X</institution-id><institution-id institution-id-type="GRID">grid.8756.c</institution-id><institution>Institute of Cardiovascular and Medical Sciences, </institution><institution>University of Glasgow, Wolfson Medical School Building, </institution></institution-wrap>University Avenue, Glasgow, G12 8QQ UK </aff>
<aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution>Department of Medical and Molecular Genetics, </institution><institution>Division of Genetics and Molecular Medicine, King’s College London School of Medicine, Guy’s Hospital, </institution></institution-wrap>London, SE1 9RT UK </aff>
<aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2034 1839</institution-id><institution-id institution-id-type="GRID">grid.21155.32</institution-id><institution></institution><institution>BGI-Shenzhen, </institution></institution-wrap>Shenzhen, 518083 China </aff>
<aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution></institution><institution>University College London (UCL) Department of Genetics, Evolution &amp; Environment (GEE), </institution></institution-wrap>Gower Street, London, WC1E 6BT UK </aff>
<aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution>MRC Integrative Epidemiology Unit, School of Social and Community Medicine, </institution><institution>University of Bristol, Oakfield House, </institution></institution-wrap>Oakfield Grove, Clifton, Bristol BS8 2BN UK </aff>
<aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution></institution><institution>University of Queensland Diamantina Institute, Translational Research Institute, </institution></institution-wrap>Brisbane, Queensland 4102 Australia </aff>
<aff id="Aff51"><label>51</label>MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, at the University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU UK </aff>
<aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution>The Genome Centre, John Vane Science Centre, </institution><institution>Queen Mary, University of London, </institution></institution-wrap>Charterhouse Square, London, EC1M 6BQ UK </aff>
<aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>Cardiovascular Genetics, BHF Laboratories, </institution><institution>Rayne Building, Institute of Cardiovascular Sciences, University College London, </institution></institution-wrap>London, WC1E 6JJ UK </aff>
<aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution></institution><institution>UCLA David Geffen School of Medicine, </institution></institution-wrap>Los Angeles, California 90095 USA </aff>
<aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9401 2774</institution-id><institution-id institution-id-type="GRID">grid.414980.0</institution-id><institution>Lady Davis Institute, </institution><institution>Jewish General Hospital, </institution></institution-wrap>Montreal, Quebec H3T 1E2 Canada </aff>
<aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution>Department of Human Genetics, </institution><institution>McGill University, </institution></institution-wrap>Montreal, Quebec H3A 1B1 Canada </aff>
<aff id="Aff57"><label>57</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution>Department of Oncology, </institution><institution>McGill University, </institution></institution-wrap>Montreal, Quebec H2W 1S6 Canada </aff>
<aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>HeLEX – Centre for Health, Law and Emerging Technologies, </institution><institution>Nuffield Department of Population Health, University of Oxford, </institution></institution-wrap>Old Road Campus, Oxford, OX3 7LF UK </aff>
<aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution>Department of Biology, </institution><institution>University of Copenhagen, </institution></institution-wrap>Ole Maaløes Vej 5, DK-2200 Copenhagen, Denmark </aff>
<aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution></institution><institution>University College London (UCL), Molecular Psychiatry Laboratory, Division of Psychiatry, </institution></institution-wrap>Gower Street, London, WC1E 6BT UK </aff>
<aff id="Aff61"><label>61</label><institution-wrap><institution-id institution-id-type="GRID">grid.421940.a</institution-id><institution></institution><institution>Adaptive Biotechnologies Corporation, </institution></institution-wrap>Seattle, Washington 98102 USA </aff>
<aff id="Aff62"><label>62</label><institution-wrap><institution-id institution-id-type="GRID">grid.264200.2</institution-id><institution>Human Genetics Research Centre, </institution><institution>St George’s University of London, </institution></institution-wrap>London, SW17 0RE UK </aff>
<aff id="Aff63"><label>63</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution>Analytic and Translational Genetics Unit, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, Massachusetts 02114 USA </aff>
<aff id="Aff64"><label>64</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Program in Medical and Population Genetics, </institution><institution>Broad Institute of Harvard and MIT, </institution></institution-wrap>Cambridge, Massachusetts 02142 USA </aff>
<aff id="Aff65"><label>65</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0578 6831</institution-id><institution-id institution-id-type="GRID">grid.451262.6</institution-id><institution></institution><institution>National Cancer Research Institute, Angel Building, </institution></institution-wrap>407 St John Street, London, EC1V 4AD UK </aff>
<aff id="Aff66"><label>66</label><institution-wrap><institution-id institution-id-type="GRID">grid.434654.4</institution-id><institution></institution><institution>Genetic Alliance UK, 4D Leroy House, </institution></institution-wrap>436 Essex Road, London, N1 3QP UK </aff>
<aff id="Aff67"><label>67</label><institution-wrap><institution-id institution-id-type="GRID">grid.264200.2</institution-id><institution>SW Thames Regional Genetics Lab, </institution><institution>St George’s University, </institution></institution-wrap>Cranmer Terrace, London, SW17 0RE UK </aff>
<aff id="Aff68"><label>68</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution>Schools of Mathematics and Social and Community Medicine, </institution><institution>University of Bristol, </institution></institution-wrap>Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN UK </aff>
<aff id="Aff69"><label>69</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>Behavioural and Brain Sciences Unit, </institution><institution>UCL Institute of Child Health, </institution></institution-wrap>London, WC1N 1EH UK </aff>
<aff id="Aff70"><label>70</label>Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec H3A 1B1 Canada </aff>
<aff id="Aff71"><label>71</label>BGI-Europe, London, EC2M 4YE UK </aff>
<aff id="Aff72"><label>72</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1013 0499</institution-id><institution-id institution-id-type="GRID">grid.14758.3f</institution-id><institution></institution><institution>National Institute for Health and Welfare (THL), </institution></institution-wrap>Helsinki, FI-00271 Finland </aff>
<aff id="Aff73"><label>73</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>Institute of Cardiovascular Science, </institution><institution>University College London, </institution></institution-wrap>Gower Street, London, WC1E 6BT UK </aff>
<aff id="Aff74"><label>74</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 4263</institution-id><institution-id institution-id-type="GRID">grid.9983.b</institution-id><institution>Cardiovascular Centre of the University of Lisbon, Faculty of Medicine, </institution><institution>University of Lisbon, </institution></institution-wrap>Avenida Professor Egas Moniz, 1649-028 Lisbon, Portugal </aff>
<aff id="Aff75"><label>75</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution></institution><institution>Wellcome Trust Centre for Human Genetics, </institution></institution-wrap>Roosevelt Drive, Oxford, OX3 7BN UK </aff>
<aff id="Aff76"><label>76</label><institution-wrap><institution-id institution-id-type="GRID">grid.434747.7</institution-id><institution></institution><institution>Illumina Cambridge Ltd, </institution></institution-wrap>Chesterford Research Park, Cambridge, CB10 1XL UK </aff>
<aff id="Aff77"><label>77</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2116 3923</institution-id><institution-id institution-id-type="GRID">grid.451056.3</institution-id><institution></institution><institution>National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas’ Foundation Trust, </institution></institution-wrap>London, SE1 9RT UK </aff>
<aff id="Aff78"><label>78</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>Department of Statistics, </institution><institution>University of Oxford, </institution></institution-wrap>1 South Parks Road, Oxford, OX1 3TG UK </aff>
<aff id="Aff79"><label>79</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution>Department of Genetics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, Massachusetts 02115 USA </aff>
<aff id="Aff80"><label>80</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution>The Patrick Wild Centre, </institution><institution>The University of Edinburgh, </institution></institution-wrap>Edinburgh, EH10 5HF UK </aff>
<aff id="Aff81"><label>81</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2336 6580</institution-id><institution-id institution-id-type="GRID">grid.7605.4</institution-id><institution>Department of Medical Sciences, </institution><institution>University of Torino, </institution></institution-wrap>10124 Torino, Italy </aff>
<aff id="Aff82"><label>82</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>Institute of Health Informatics, Farr Institute of Health Informatics Research, </institution><institution>University College London (UCL), </institution></institution-wrap>222 Euston Road, London, NW1 2DA UK </aff>
<aff id="Aff83"><label>83</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution>Usher Institute of Population Health Sciences and Informatics, </institution><institution>University of Edinburgh, </institution></institution-wrap>9 Little France Road, Edinburgh, EH16 4UX UK </aff>
<aff id="Aff84"><label>84</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 0211</institution-id><institution-id institution-id-type="GRID">grid.38678.32</institution-id><institution>Department of Mathematics, </institution><institution>Université de Québec À Montréal, </institution></institution-wrap>Montréal, Québec H3C 3P8 Canada </aff>
<aff id="Aff85"><label>85</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution>Institute for Molecular Medicine Finland (FIMM), </institution><institution>University of Helsinki, </institution></institution-wrap>Helsinki, FI-00014 Finland </aff>
<aff id="Aff86"><label>86</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Program in Medical and Population Genetics and Genetic Analysis Platform, </institution><institution>The Broad Institute of MIT and Harvard, </institution></institution-wrap>Cambridge, Massachusetts 02132 USA </aff>
<aff id="Aff87"><label>87</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0462 7212</institution-id><institution-id institution-id-type="GRID">grid.1006.7</institution-id><institution>Institute of Neuroscience, Henry Wellcome Building for Neuroecology, </institution><institution>Newcastle University, </institution></institution-wrap>Framlington Place, Newcastle upon Tyne, NE2 4HH UK </aff>
<aff id="Aff88"><label>88</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution></institution><institution>University of Helsinki, Department of Psychiatry, </institution></institution-wrap>Helsinki, FI-00014 Finland </aff>
<aff id="Aff89"><label>89</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0398 9627</institution-id><institution-id institution-id-type="GRID">grid.416568.8</institution-id><institution>North West Thames Regional Genetics Service, </institution><institution>Kennedy-Galton Centre, Northwick Park Hospital, </institution></institution-wrap>Watford Road, Harrow, HA1 3UJ UK </aff>
<aff id="Aff90"><label>90</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution></institution><institution>University College London (UCL) Genetics Institute (UGI), </institution></institution-wrap>Gower Street, London, WC1E 6BT UK </aff>
<aff id="Aff91"><label>91</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0463 9178</institution-id><institution-id institution-id-type="GRID">grid.419127.8</institution-id><institution>Connective Tissue Disorders Service, Sheffield Diagnostic Genetics Service, </institution><institution>Sheffield Children’s NHS Foundation Trust, Western Bank, </institution></institution-wrap>Sheffield, S10 2TH UK </aff>
<aff id="Aff92"><label>92</label>Centre for Genomic and Experimental Medicine, Institute of Genetics and Experimental Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU UK </aff>
<aff id="Aff93"><label>93</label><institution-wrap><institution-id institution-id-type="GRID">grid.239826.4</institution-id><institution>Molecular Genetics, </institution><institution>Viapath at Guy’s Hospital, </institution></institution-wrap>London, SE1 9RT UK </aff>
<aff id="Aff94"><label>94</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution>ALSPAC &amp; School of Social and Community Medicine, </institution><institution>University of Bristol, Oakfield House, </institution></institution-wrap>Oakfield Grove, Clifton, Bristol BS8 2BN UK </aff>
<aff id="Aff95"><label>95</label><institution-wrap><institution-id institution-id-type="GRID">grid.461760.2</institution-id><institution>Human Genetics Department, </institution><institution>Radboudumc and Radboud Institute for Molecular Life Sciences (RIMLS), </institution></institution-wrap>Geert Grooteplein 25, Nijmegen, 6525 HP The Netherlands </aff>
<aff id="Aff96"><label>96</label><institution-wrap><institution-id institution-id-type="GRID">grid.420468.c</institution-id><institution>Department of Clinical Genetics, </institution><institution>Great Ormond Street Hospital, </institution></institution-wrap>London, WC1N 3JH UK </aff>
<aff id="Aff97"><label>97</label><institution-wrap><institution-id institution-id-type="GRID">grid.420545.2</institution-id><institution>Clinical Genetics, </institution><institution>Guy’s &amp; St Thomas’ NHS Foundation Trust, </institution></institution-wrap>London, SE1 9RT UK </aff>
<aff id="Aff98"><label>98</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9009 9462</institution-id><institution-id institution-id-type="GRID">grid.416266.1</institution-id><institution>Mackenzie Building, Kirsty Semple Way, </institution><institution>Ninewells Hospital and Medical School, </institution></institution-wrap>Dundee, DD2 4RB UK </aff>
<aff id="Aff99"><label>99</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7291</institution-id><institution-id institution-id-type="GRID">grid.7107.1</institution-id><institution>Institute of Medical Sciences, </institution><institution>University of Aberdeen, </institution></institution-wrap>Aberdeen, AB25 2ZD UK </aff>
<aff id="Aff100"><label>100</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution>School of Oral and Dental Sciences, </institution><institution>University of Bristol, </institution></institution-wrap>Lower Maudlin Street, Bristol, BS1 2LY UK </aff>
<aff id="Aff101"><label>101</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution>School of Experimental Psychology, </institution><institution>University of Bristol, </institution></institution-wrap>12a Priory Road, Bristol, BS8 1TU UK </aff>
<aff id="Aff102"><label>102</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0400 6581</institution-id><institution-id institution-id-type="GRID">grid.412925.9</institution-id><institution>National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit, </institution><institution>Glenfield Hospital, </institution></institution-wrap>Leicester, LE3 9QP UK </aff>
<aff id="Aff103"><label>103</label>Maritime Medical Genetics Service, 5850/5980 University Avenue, PO Box 9700, Halifax, Nova Scotia B3K 6R8 Canada </aff>
<aff id="Aff104"><label>104</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution>Queensland Brain Institute, </institution><institution>University of Queensland, </institution></institution-wrap>Brisbane, Queensland 4072 Australia </aff>
<aff id="Aff105"><label>105</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0619 1117</institution-id><institution-id institution-id-type="GRID">grid.412125.1</institution-id><institution>Princess Al Jawhara Albrahim Center of Excellence in the Research of Hereditary Disorders, </institution><institution>King Abdulaziz University, </institution></institution-wrap>P.O. Box 80200, Jeddah, 21589 Saudi Arabia </aff>
<aff id="Aff106"><label>106</label>Macau University of Science and Technology, Avenida Wai long, Taipa, Macau 999078 China </aff>
<aff id="Aff107"><label>107</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121742757</institution-id><institution-id institution-id-type="GRID">grid.194645.b</institution-id><institution>Department of Medicine and State Key Laboratory of Pharmaceutical Biotechnology, </institution><institution>University of Hong Kong, </institution></institution-wrap>21 Sassoon Road, Pok Fu Lam, Hong Kong </aff>
<aff id="Aff108"><label>108</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>The Centre for Translational Omics – GOSgene, </institution><institution>UCL Institute of Child Health, </institution></institution-wrap>London, WC1N 1EH UK </aff>
<aff id="Aff109"><label>109</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7910</institution-id><institution-id institution-id-type="GRID">grid.1012.2</institution-id><institution>School of Medicine and Pharmacology, </institution><institution>University of Western Australia, </institution></institution-wrap>Perth, Western Australia 6009 Australia </aff>
<aff id="Aff110"><label>110</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0437 5942</institution-id><institution-id institution-id-type="GRID">grid.3521.5</institution-id><institution>Department of Endocrinology and Diabetes, </institution><institution>Sir Charles Gairdner Hospital, </institution></institution-wrap>Nedlands, Western Australia 6009 Australia </aff>
<aff id="Aff111"><label>111</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1956 2722</institution-id><institution-id institution-id-type="GRID">grid.7048.b</institution-id><institution>Department of Public Health, </institution><institution>Section for Epidemiology, Aarhus University, </institution></institution-wrap>Aarhus, Denmark </aff>
<aff id="Aff112"><label>112</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 7349</institution-id><institution-id institution-id-type="GRID">grid.27530.33</institution-id><institution>Department of Cardiology, </institution><institution>Aalborg University Hospital, </institution></institution-wrap>Aalborg, Denmark </aff>
<aff id="Aff113"><label>113</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2175 6024</institution-id><institution-id institution-id-type="GRID">grid.417390.8</institution-id><institution>Diet, Genes and Environment, </institution><institution>Danish Cancer Society Research Center, </institution></institution-wrap>Copenhagen, Denmark </aff>
<aff id="Aff114"><label>114</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2284 9388</institution-id><institution-id institution-id-type="GRID">grid.14925.3b</institution-id><institution>INSERM, Centre for Research in Epidemiology and Population Health (CESP), </institution><institution>U1018, Nutrition, Hormones, and Women’s Health Team, Institut Gustave Roussy, </institution></institution-wrap>Villejuif, France </aff>
<aff id="Aff115"><label>115</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0492 0584</institution-id><institution-id institution-id-type="GRID">grid.7497.d</institution-id><institution>Division of Cancer Genetic Epidemiology, </institution><institution>German Cancer Research Centre (DKFZ), </institution></institution-wrap>im Neuenheimer Feld 581, 69121 Heidelberg, Germany </aff>
<aff id="Aff116"><label>116</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0390 0098</institution-id><institution-id institution-id-type="GRID">grid.418213.d</institution-id><institution>Department of Epidemiology, </institution><institution>German Institute of Human Nutrition (DIfE), </institution></institution-wrap>PotsdamRehbrücke, Germany </aff>
<aff id="Aff117"><label>117</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2155 0800</institution-id><institution-id institution-id-type="GRID">grid.5216.0</institution-id><institution>WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, </institution><institution>Epidemiology and Medical Statistics, University of Athens Medical School, </institution></institution-wrap>Athens, Greece </aff>
<aff id="Aff118"><label>118</label><institution-wrap><institution-id institution-id-type="GRID">grid.424637.0</institution-id><institution></institution><institution>Hellenic Health Foundation, </institution></institution-wrap>Athens, Greece </aff>
<aff id="Aff119"><label>119</label><institution-wrap><institution-id institution-id-type="ISNI">0000000405980095</institution-id><institution-id institution-id-type="GRID">grid.17703.32</institution-id><institution></institution><institution>IARC, </institution></institution-wrap>Lyon, France </aff>
<aff id="Aff120"><label>120</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1758 0566</institution-id><institution-id institution-id-type="GRID">grid.417623.5</institution-id><institution>Molecular and Nutritional Epidemiology Unit, </institution><institution>Centro per lo Studio e la Prevenzione Oncologica-Scientific Institute of Tuscany, </institution></institution-wrap>Florence, Italy </aff>
<aff id="Aff121"><label>121</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0807 2568</institution-id><institution-id institution-id-type="GRID">grid.417893.0</institution-id><institution>Epidemiology and Prevention Unit, </institution><institution>Fondazione IRCCS Istituto Nazionale dei Tumori, </institution></institution-wrap>Milan, Italy </aff>
<aff id="Aff122"><label>122</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0790 385X</institution-id><institution-id institution-id-type="GRID">grid.4691.a</institution-id><institution>Dipartimento di Medicina Clinica e Chirurgia, </institution><institution>Federico II University, </institution></institution-wrap>Naples, Italy </aff>
<aff id="Aff123"><label>123</label>Cancer Registry and Histopathology Unit, Civic- M.P.Arezzo Hospital, ASP Ragusa, Italy </aff>
<aff id="Aff124"><label>124</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1784 6598</institution-id><institution-id institution-id-type="GRID">grid.428948.b</institution-id><institution></institution><institution>Human Genetics Foundation, </institution></institution-wrap>Turin, Italy </aff>
<aff id="Aff125"><label>125</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2336 6580</institution-id><institution-id institution-id-type="GRID">grid.7605.4</institution-id><institution></institution><institution>Department of Medical Sciences, University of Turin, </institution></institution-wrap>Turin, Italy </aff>
<aff id="Aff126"><label>126</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2208 0118</institution-id><institution-id institution-id-type="GRID">grid.31147.30</institution-id><institution>Centre for Nutrition, Prevention and Health Services, </institution><institution>National Institute for Public Health and the Environment (RIVM), </institution></institution-wrap>Bilthoven, The Netherlands </aff>
<aff id="Aff127"><label>127</label><institution-wrap><institution-id institution-id-type="ISNI">0000000090126352</institution-id><institution-id institution-id-type="GRID">grid.7692.a</institution-id><institution>Julius Center for Health Sciences and Primary Care, </institution><institution>University Medical Center Utrecht, </institution></institution-wrap>Utrecht, The Netherlands </aff>
<aff id="Aff128"><label>128</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122595234</institution-id><institution-id institution-id-type="GRID">grid.10919.30</institution-id><institution>Department of Community Medicine, Faculty of Health Sciences, </institution><institution>University of Tromsø, The Arctic University of Norway, </institution></institution-wrap>Tromsø, Norway </aff>
<aff id="Aff129"><label>129</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0727 140X</institution-id><institution-id institution-id-type="GRID">grid.418941.1</institution-id><institution>Department of Research, Cancer Registry of Norway, </institution><institution>Institute of Population-Based Cancer Research, </institution></institution-wrap>Oslo, Norway </aff>
<aff id="Aff130"><label>130</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Department of Medical Epidemiology and Biostatistics, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff131"><label>131</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0409 6302</institution-id><institution-id institution-id-type="GRID">grid.428673.c</institution-id><institution>Genetic Epidemiology Group, </institution><institution>Folkhälsan Research Center, </institution></institution-wrap>Helsinki, Finland </aff>
<aff id="Aff132"><label>132</label>Public Health Directorate, Asturias, Spain </aff>
<aff id="Aff133"><label>133</label>Public Health Institute of Navarra, Pamplona, Spain </aff>
<aff id="Aff134"><label>134</label>Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain </aff>
<aff id="Aff135"><label>135</label>Epidemiology Department, Murcia Health Authority, Murcia, Spain </aff>
<aff id="Aff136"><label>136</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1756 6246</institution-id><institution-id institution-id-type="GRID">grid.466571.7</institution-id><institution></institution><institution>Centro de Investigación Biomédica en red en Epidemiología y Salud Pública, </institution></institution-wrap>Barcelona, Spain </aff>
<aff id="Aff137"><label>137</label>Public Health Division of Gipuzkoa, Instituto Bio-Donostia, Basque Government, CIBERESP, Gipuzkoa, Spain </aff>
<aff id="Aff138"><label>138</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution>CRR, </institution><institution>Lund University, </institution></institution-wrap>20502 Malmö, Sweden </aff>
<aff id="Aff139"><label>139</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1034 3451</institution-id><institution-id institution-id-type="GRID">grid.12650.30</institution-id><institution>Department of Public Health and Clinical Medicine, </institution><institution>Family Medicine, Umeå University, </institution></institution-wrap>Umeå, Sweden </aff>
<aff id="Aff140"><label>140</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>Cancer Epidemiology Unit, Nuffield Department of Population Health, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, UK </aff>
<aff id="Aff141"><label>141</label>German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>29</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>7</volume>
<elocation-id>4394</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Obesity is a genetically heterogeneous disorder. Using targeted and whole-exome sequencing, we studied 32 human and 87 rodent obesity genes in 2,548 severely obese children and 1,117 controls. We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in <italic>GNAS</italic>, which were sometimes found with accelerated growth rather than short stature as described previously. Nominally significant associations were found for rare functional variants in <italic>BBS1</italic>, <italic>BBS9</italic>, <italic>GNAS</italic>, <italic>MKKS</italic>, <italic>CLOCK</italic> and <italic>ANGPTL6</italic>. The p.S284X variant in <italic>ANGPTL6</italic> drives the association signal (rs201622589, MAF~0.1%, odds ratio = 10.13, p-value = 0.042) and results in complete loss of secretion in cells. Further analysis including additional case-control studies and population controls (N = 260,642) did not support association of this variant with obesity (odds ratio = 2.34, p-value = 2.59 × 10<sup>−3</sup>), highlighting the challenges of testing rare variant associations and the need for very large sample sizes. Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in <italic>ANGPTL6</italic> and other genes that lead to obesity when deleted in mice, do contribute to obesity. Such studies may yield druggable targets for weight loss therapies.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Studies focused on severe early onset obesity alone, or obesity with developmental delay and/or dysmorphic features have identified a number of genes harbouring highly penetrant causal mutations<sup><xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref></sup>. The further characterisation of rare, highly penetrant variants identified in such individuals can provide insights into the cellular and physiological mechanisms involved in energy homeostasis and human obesity, and can identify and/or validate targets for therapeutic intervention. The aim of our study was to examine the prevalence of rare/novel variants in human and mouse obesity genes using high-throughput next-generation sequencing in a large cohort of individuals with severe early onset obesity. Here we describe results from an analysis of 119 candidate genes sequenced in 2,548 individuals with severe, early-onset obesity from the Severe Childhood Onset Obesity Project (SCOOP)<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> (UK individuals of European ancestry recruited to the Genetics of Obesity Study, GOOS; BMI standard deviation score (SDS) &gt; 3; onset of obesity before the age of 10 years; Methods) from the UK10K project<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Our analysis includes 737 SCOOP individuals with whole-exome sequence, and 1,811 additional SCOOP individuals, not consented for whole-exome analysis, in whom we performed targeted sequencing. As this work was performed as part of a consortium (UK10K project), this data was compared to 1,117 individuals with other disorders (e.g. neurodevelopmental and rare disease) in whom exome sequencing and analysis were performed using the same methods. For the purposes of this analysis, these individuals are designated as “controls” (Methods), although we recognise that there are limitations with this design.</p>
</sec>
<sec id="Sec2">
<title>Study Design</title>
<p id="Par3">SCOOP individuals likely to have congenital leptin deficiency, a treatable cause of severe obesity, were excluded by measurement of serum leptin, and individuals with mutations in the melanocortin 4 receptor gene (<italic>MC4R</italic>) (the most common genetic form of penetrant obesity) were excluded by prior Sanger sequencing.</p>
<p id="Par4">We focused on six tiers of genes (Methods and Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>): (1) genes known to harbour variants causing human obesity alone (<italic>Obesity Alone</italic>; n = 6); (2) genes in which known variants cause human obesity combined with developmental delay and/or dysmorphology (<italic>Obesity and Delay;</italic> n = 26); (3) genes in which loss-of-function leads to obesity in mice (<italic>LoF Mice</italic>; n = 51); (4) genes in which gain-of-function leads to obesity in mice (<italic>GoF Mice</italic>, n = 5); (5) genes encoding anorectic peptides and their receptors (<italic>Anorectic Molecules</italic>, n = 7), and (6) genes in which loss-of-function is associated with other metabolic phenotypes in mice (<italic>Complex Metabolic Effects</italic>, n = 24). Our aim was to include genes where there was sufficient evidence to indicate disorders with Mendelian inheritance (obesity syndromes) or where complete deletion or overexpression (as opposed to conditional knockouts) causes an obesity phenotype in mice (Methods) (i.e. genes in which inherited loss/gain of function variants might exist). To identify variants more likely to be causally linked to obesity, we focused on <bold><italic>rare</italic></bold> (MAF &lt; 1%) and <bold><italic>novel</italic></bold> (not seen in the data we used for filtering) variants predicted to be functional (i.e. nonsense variants, missense amino acid substitutions, alterations of conserved splice sites or small insertions/deletions (indels) that introduced a frameshift) (Methods). We filtered our data against approximately 8,000 publicly available sequenced samples, as well as 2,097 exomes (sequenced in parallel on the same platform as our samples) and 3,781 whole-genome sequenced samples also from the UK10K project (Methods).</p>
<sec id="Sec3">
<title>Human Obesity Syndrome Genes</title>
<p id="Par5">Firstly, we sought to identify rare and novel functional variants in the 32 genes known to cause human obesity, with or without, additional developmental delay and/or dysmorphology features (<italic>Obesity Alone</italic>, or <italic>Obesity and Delay</italic>) (Methods). We identified 11 rare potentially functional variants in ClinVar with pathogenic/likely pathogenic status and 321 novel functional variants, which we confirmed by Sanger sequencing (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Methods). Based on inheritance patterns (where available) and the functional properties of variants that have previously been characterised, variants in these genes may contribute to obesity, sometimes in a non-fully penetrant manner, in 52 (2%) individuals (Supplementary Figure <xref ref-type="media" rid="MOESM2">1</xref> &amp; Supplementary Table <xref ref-type="media" rid="MOESM1">2</xref>; Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Methods). As variants in <italic>MC4R</italic> account for approximately 5% of severe obesity in this cohort<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, these findings indicate that &gt; 90% of patients within this cohort do not have their phenotype explained by variants in known human obesity genes. Further analysis exploring the whole-exome in an agnostic manner, with appropriately matched non-disease controls not available in the UK10K project, will be an aim of future investigations.<fig id="Fig1"><label>Figure 1</label><caption><p>Identification of clinically-associated variants in known human obesity genes. Schematic outlining the analysis strategy.</p></caption><graphic id="d29e4254" xlink:href="41598_2017_3054_Fig1_HTML"></graphic></fig>
<fig id="Fig2"><label>Figure 2</label><caption><p>Pedigrees of patients with clinically associated variants contributing to obesity Co-segregation of variants is shown where male (squares) and female (circles) family members consented to genotyping. Heterozygous (filled) and wild-type (empty) mutation carriers are indicated; in some cases, individuals were not available for genotyping (grey). Body mass index (BMI) (&gt;27 kg/m<sup>2</sup> = overweight;&gt;30 kg/m<sup>2</sup> = obesity) for adults and BMI standard deviation scores (BMI sds) for children are shown where data was available. (<bold>A)</bold> Obesity alone; (<bold>B)</bold> Obesity and Delay. <italic>MC4R</italic> mutations were excluded by prior Sanger sequencing of all individuals undergoing whole exome sequencing and the majority (1744/1811) of individuals undergoing targeted resequencing. The finding of four <italic>MC4R</italic> mutations in the remaining 82 individuals is in keeping with the prevalence of heterozygous <italic>MC4R</italic> mutations in this cohort as reported previously<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p></caption><graphic id="d29e4290" xlink:href="41598_2017_3054_Fig2_HTML"></graphic></fig>
</p>
<p id="Par6">Notably, we identified thirteen clinically associated <italic>GNAS</italic> variants in fourteen SCOOP individuals (12 of these confirmed on Sanger sequencing; 0.5%) (Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>). <italic>GNAS</italic> is an imprinted gene in which heterozygous loss-of-function variants are associated with obesity, short stature and skeletal abnormalities, and, when maternally inherited, hormone resistance syndromes<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. As <italic>GNAS</italic> sequencing has traditionally only been performed in individuals with classical clinical features, our findings suggest that the true prevalence in childhood obesity may be underappreciated. Three of the variants found in our study have been described previously in patients with classical features (p.Y163X<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>; p.R258W<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, and p.R265H<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>). We identified a novel nonsense variant (p.Y169X) predicted to remove the entire Ras-like GTPase domain and several missense variants predicted to affect downstream signalling by affecting the interaction with G-protein coupled receptors (GPCRs), G-protein β- and γ-subunits, or downstream adenylyl cyclase when mapped onto the protein structure of GNAS (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). We confirmed maternal transmission of variants in three out of the five families where parental samples were available for genotyping. Although four <italic>GNAS</italic> variant carriers exhibited endocrinopathies and nine had developmental delay as anticipated, unexpectedly four individuals had accelerated linear growth in childhood (height SDS &gt; 2) rather than short stature (defined as height sds &lt; 2.0) (Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>). Further molecular and physiological studies will be needed to investigate potential genotype-phenotype correlations. As studies in rodents have shown that <italic>Gnas</italic> is imprinted in the paraventricular nucleus of the hypothalamus<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, the location of the majority of neurons expressing the G-protein coupled receptor MC4R, it is plausible to hypothesize that some <italic>GNAS</italic> variants may contribute to obesity and accelerated linear growth by reducing melanocortin signalling.<fig id="Fig3"><label>Figure 3</label><caption><p>Structural model of variants identified in GNAS. (<bold>A</bold>) Structure of the active state ternary protein complex of G-protein coupled receptor (GPCR) beta 2-adrenergic receptor (ADRB2), and the nucleotide-free Gs heterotrimer, composed of Gs-α(GNAS), Gs-β, and Gs-γ subunits (based on Rasmussen <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, pdb file: 3sn6). The two major domains of GNAS are noted, α-helical domain and Ras-like GTPase domain. The principal interactions between GNAS and GPCRs involve the amino- and carboxy-terminal α-helices. The Ras-like GTPase domain contains most of the catalytic residues necessary for GTP hydrolysis, as well as the Gβγ and effector binding regions (switch regions I, II and III), which change confirmation upon binding to GTP or GDP). (<bold>B</bold>) Structure of the complex of Gs-alpha with the catalytic domains of mammalian adenylyl cyclase (based on Tesmer <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, pdb file: 1azs). Variant residues (purple), and the different components of the complex are highlighted.</p></caption><graphic id="d29e4372" xlink:href="41598_2017_3054_Fig3_HTML"></graphic></fig>
</p>
<p id="Par7">Next we formally tested for enrichment of rare, or novel, functional variants in case-control analysis<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> (Methods). Although no gene attained experiment-wide threshold of p-value &lt; 2 × 10<sup>−4</sup> (Methods and Supplementary Tables <xref ref-type="media" rid="MOESM1">4</xref>–<xref ref-type="media" rid="MOESM1">9</xref>), four genes (<italic>BBS1</italic>, <italic>BBS9</italic>, <italic>GNAS</italic>, and <italic>MKKS</italic>) known to cause obesity and developmental delay and/or dysmorphology (<italic>Obesity and Delay</italic>) had nominally significant burden test p-values (p-value &lt; 0.05) and a higher burden of variants in cases than controls (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of case-control results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Tier</th><th># Variants</th><th>Rare alleles in SCOOP TS (N = 1,811)</th><th>Rare alleles in SCOOP WES (N = 737)</th><th>Rare alleles in Control WES (N = 1,117)</th><th colspan="2">OR</th><th>Adjusted OR</th><th>p-value SKATO</th><th>p-value BURDEN</th></tr></thead><tbody><tr><td colspan="11">Rare Functional</td></tr><tr><td>
<italic>BBS1</italic>
</td><td>Obesity and Delay</td><td>18</td><td>36</td><td>18</td><td>10</td><td colspan="2">2.368</td><td></td><td>
<bold>0.022</bold>
</td><td>
<bold>0.018</bold>
</td></tr><tr><td>
<italic>BBS9</italic>
</td><td>Obesity and Delay</td><td>20</td><td>24</td><td>5</td><td>5</td><td colspan="2">2.543</td><td></td><td>0.081</td><td>
<bold>0.045</bold>
</td></tr><tr><td>
<italic>GNAS</italic>
</td><td>Obesity and Delay</td><td>14</td><td>12</td><td>4</td><td>0</td><td colspan="2">Inf</td><td>14.505</td><td>
<bold>0.015</bold>
</td><td>
<bold>0.008</bold>
</td></tr><tr><td>
<italic>MKKS</italic>
</td><td>Obesity and Delay</td><td>19</td><td>90</td><td>25</td><td>28</td><td colspan="2">1.801</td><td></td><td>
<bold>0.006</bold>
</td><td>
<bold>0.007</bold>
</td></tr><tr><td>
<italic>ANGPTL6</italic>
</td><td>Mouse LOF</td><td>12</td><td>18</td><td>10</td><td>4</td><td colspan="2">3.073</td><td></td><td>
<bold>0.043</bold>
</td><td>
<bold>0.027</bold>
</td></tr><tr><td colspan="11">Novel Functional</td></tr><tr><td>
<italic>GNAS</italic>
</td><td>Obesity and Delay</td><td>13</td><td>11</td><td>4</td><td colspan="2">0</td><td>Inf</td><td>13.629</td><td>
<bold>0.019</bold>
</td><td>
<bold>0.010</bold>
</td></tr><tr><td>
<italic>CLOCK</italic>
</td><td>Mouse LOF</td><td>9</td><td>8</td><td>2</td><td colspan="2">0</td><td>Inf</td><td>9.208</td><td>0.066</td><td>
<bold>0.036</bold>
</td></tr></tbody></table><table-wrap-foot><p>Summary of case-control results in genes with nominally significant (p-value &lt; 0.05, bold) burden of <italic>Rare</italic> (top) or <italic>Novel</italic> (bottom) functional variants in SCOOP cases (N = 1,811 with targeted sequence and N = 737 with whole-exome sequence), compared to 1,117 controls with whole-exome sequence data from the UK10K project. The number of variants (# variants) per gene are shown, as well as the number of alleles in cases and controls, odds ratios (OR) and p-values from SKAT-O (p-value SKATO) and from burden tests (p-value BURDEN). For variants not detected in controls an adjusted odds ratio (Adjusted OR) was calculated by adding 0.5 to the number of alleles in each cell of the two-by-two table.</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec4">
<title>Mouse Obesity Genes</title>
<p id="Par8">We found a higher burden of rare variants in cases than controls for two genes known to cause obesity when disrupted in mice - <italic>ANGPTL6</italic> and <italic>CLOCK</italic> (Table <xref ref-type="table" rid="Tab1">1</xref>). Testing the functional consequences of <italic>CLOCK</italic> variants in cells is not straightforward as the molecular mechanisms that lead to obesity are not fully understood. As such, we focused on verifying the accuracy of the computationally predicted function of all twelve rare <italic>ANGPTL6</italic> variants (Methods, Fig. <xref ref-type="fig" rid="Fig4">4</xref>, Supplementary Table <xref ref-type="media" rid="MOESM1">10</xref>). All variants found in cases (but not the one variant found exclusively in controls, V143L) were predicted to affect the fibrinogen-like domain of the protein (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>)<italic>. ANGPTL6</italic> is predominantly expressed in the liver but is also expressed in white adipose tissue and kidney. To evaluate the effect of these variants, HEK293 cells were transiently transfected with constructs encoding wild type and variant forms of <italic>ANGPTL6</italic>. Whereas wild-type ANGPTL6 was readily detected in the medium, several mutants reduced, and the S286X mutant abolished, secretion of <italic>ANGPTL6</italic> (Fig. <xref ref-type="fig" rid="Fig4">4b</xref>). Incorporation of this functional information did not qualitatively change the results of the <italic>ANGPTL6</italic> gene-based test (Supplementary Table <xref ref-type="media" rid="MOESM1">10</xref>). However, limiting the analysis to the single variant that completely abolished protein secretion (p.S286X, rs201622589) led to an adjusted OR = 10.13 and p-value = 0.028 (Fisher’s p-value = 0.041) suggesting that the association signal at this gene is primarily driven by this variant (Supplementary Table <xref ref-type="media" rid="MOESM1">10</xref>). To increase power, and given that there were no additional cases of European descent from our obesity cohort, we analysed existing exome-chip data from an additional 253,587 unrelated European, non-Finnish population controls (Methods, Supplementary Table <xref ref-type="media" rid="MOESM1">11</xref>). In an updated analysis with the 2,548 cases and 253,587 controls, we observed an odds ratio (OR) = 2.90 and a Fisher’s p-value = 0.0022, which did not reach experiment or exome-wide significance. Further analysis of 1,436 non-overlapping obesity cases and 1,954 non-overlapping controls from two studies did not lend additional support, and when combined with the original data, yielded an overall OR = 2.34 and chi-squared p-value = 0.0060 (total 3,984 cases vs 256,658 controls, Supplementary Table <xref ref-type="media" rid="MOESM1">11</xref>). The results are similar when limiting to non-obese controls (Supplementary Table <xref ref-type="media" rid="MOESM1">12</xref>). These findings highlight the difficulty in studying very rare variants in complex diseases, and potentially the effect of winner’s curse, reinforcing the need for extremely large sample sizes<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Of interest, mice with targeted deletion of <italic>Angptl6</italic> that survive to birth (20%) develop marked obesity, have increased food intake, reduced energy expenditure, exhibit lipid accumulation in liver and muscle, and develop insulin resistance<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Conversely, mice with targeted overexpression of <italic>Angptl6</italic> are lean, insulin sensitive and are protected from diet-induced obesity<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. As ANGPTL6 is a liver-derived circulating peptide, and thus could potentially be manipulated for therapeutic purposes<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, further genetic studies in larger cohorts and experimental studies in mice and humans are necessary to explore its role in obesity and potential utility as an anti-obesity drug target.<fig id="Fig4"><label>Figure 4</label><caption><p>Functional characterisation of ANGPTL6 variants location and functional effect (<bold>A</bold>) Human ANGPTL6 protein and location of the genetic variants. Schematic of the human ANGPTL6 protein with the three recognisable domains: signal peptide (SP) in green, coiled-coil domain (CCD) in purple, and fibrinogen-like domain (FLD) in yellow. As all genetic variants identified are located predominantly in the FLD, the partial tertiary structure of the C-terminal protein portion (amino acids 135–470), based on previously solved fibrinogen structure (1lwu) is presented. The single variant seen in controls only is shown in blue, variants identified in cases are in purple, the S284X variant is starred. (<bold>B</bold>) Functional characterisation of ANGPTL6 variants. Cells were transiently transfected with constructs encoding wild-type (WT) or mutant ANGPTL6; levels of protein secretion into the media were measured by ELISA; means+/− standard deviation (SD) for experiments performed in triplicate are shown (results were confirmed by Western blotting; data not shown). Statistical significance was measured using unpaired T-test with Welch’s correction using the GraphPad Prism software. *p &lt; 0.05; ***p &lt; 0.001.</p></caption><graphic id="d29e4844" xlink:href="41598_2017_3054_Fig4_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec5">
<title>Power and Gene Set Analysis</title>
<p id="Par9">Assuming an experiment-wide significance level of 2 × 10<sup>−4</sup> and that 30% of rare (MAF &lt; 1%) variants within a given gene are causal we have very limited power (~20%) to detect an association to a gene region using our sample of 2,548 cases and 1,117 controls (Supplementary Figure <xref ref-type="media" rid="MOESM2">2</xref>, Online Methods, Supplementary Note <xref ref-type="media" rid="MOESM2">4</xref>)<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. As there is evidence that looking across group of genes with stronger priors may increase power<sup><xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref></sup>, we tested for association of rare or novel functional variants within each of the six candidate gene sets. We further filtered variants with respect to their likelihood of being deleterious and performed six nested tests for each gene set (Methods). Although none of the analyses of tiered gene sets reached experiment-wide significance (Supplementary Table <xref ref-type="media" rid="MOESM1">13</xref>, Fig. <xref ref-type="fig" rid="Fig5">5</xref>), we see an increase in OR as we focus on rarer variants with more evidence of predicted deleterious effect within the <italic>Obesity Alone</italic> gene set. This suggests that focusing on extremely rare variants with strong evidence of being deleterious may be a good strategy for diseases with a complex genetic architecture, which likely includes rare, highly penetrant alleles. Our power analyses also suggests that restricting the MAF threshold to be near the very rare allele frequency of that expected for the causal variants, rather than a more lenient MAF threshold of 1%, increases power (Supplementary Figure <xref ref-type="media" rid="MOESM2">3</xref>). Finally, there are nominally significant signals (p-value &lt; 0.05) within the <italic>LoF Mice</italic> candidate gene set for the novel, functional variant tests suggesting that within this rather large gene set (n = 51) there may be additional genes associated with human early onset obesity (Fig. <xref ref-type="fig" rid="Fig5">5</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>Tiered analysis of obesity candidate genes sets. ORs (bars) and 95% (dotted vertical lines) confidence intervals for each of the six gene tiers and across all 119 genes combined each for eight different filtering scenarios by MAF (<italic>Rare</italic> or <italic>Novel</italic>) and functional prediction (synonymous - <italic>Synon</italic>, functional - <italic>Func</italic>, functional with at least 1 deleterious consequence prediction – <italic>Func</italic>, <italic>1 + del</italic>, and functional with all deleterious consequence predictions - <italic>Func</italic>, <italic>all del</italic>).</p></caption><graphic id="d29e4924" xlink:href="41598_2017_3054_Fig5_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec6" sec-type="discussion">
<title>Discussion</title>
<p id="Par10">In summary, analysis of sequence data in 119 genes across 2,548 severely obese children and 1,117 other disease controls from the UK10K project identified variants in known obesity genes, contributing to obesity in 2% of children within this cohort, in whom mutations in MC4R and leptin had been excluded. It also highlighted that <italic>GNAS</italic> mutations may be more prevalent in human obesity than previously thought, and that the spectrum of phenotypic consequences may be broader and more heterogeneous than previously described (6). Additional detailed genotype-phenotype studies will be required to further elucidate the molecular underpinnings of the physiological consequences of these variants.</p>
<p id="Par11">Taking the information generated in this study together with the published literature, we suggest that molecular genetic investigations, including testing known obesity genes, or agnostic exome-wide or genome-wide approaches (as these become more established at the point of care), should become part of the assessment for a child presenting with severe obesity (BMI SDS &gt; 3) in the absence of other syndromic features. Genetic studies can allow the identification of congenital leptin deficiency which is entirely treatable with recombinant leptin therapy<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Also, early reports suggest that patients with mutations that disrupt POMC signalling may be effectively treated with Setmelanotide (a MC4R agonist)<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Finally, our data suggest that focusing on very rare, deleterious variants may increase power to find genetic association. Further detailed investigation of genes that lead to obesity when deleted in mice may identify new pathophysiological mechanisms involved in human obesity that can be targeted for drug discovery.</p>
</sec>
<sec id="Sec7" sec-type="materials|methods">
<title>Methods</title>
<sec id="Sec8">
<title>Sample Sets</title>
<p id="Par12">All studies were approved by the Cambridge Local Research Ethics Committee and all participants and their parents gave written informed consent. All methods were performed in accordance with the relevant laboratory/clinical guidelines and regulations.</p>
<p id="Par13">The SCOOP cohort<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> was studied as part of the UK10K consortium<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Data was compared to subsets within the neurodevelopmental and rare disease groups that were consented for use as controls. Details and further information about the UK10K project can be found at <ext-link ext-link-type="uri" xlink:href="http://www.uk10k.org/">http://www.uk10k.org/</ext-link> and in the UK10K consortium paper from 2015<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p>
<p id="Par14">We gathered the genotypes for the variant S284X (rs201622589) in 202,981 unrelated population controls with European non-Finnish ancestry from existing cohorts (UKHLS<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, Fenland, EPIC Norfolk<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, CCHS<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>, CGPS<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>, CIHDS<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>, EPIC-CVD<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, UK Biobank<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> and ExAC<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>) and in two additional studies of obese children and healthy or thin controls<sup><xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref></sup> including one from the Leipzig Childhood Obesity Cohort<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. (Supplementary Note <xref ref-type="media" rid="MOESM2">1</xref>)</p>
</sec>
<sec id="Sec9">
<title>Sequencing, Variant Calling, and Quality Control</title>
<p id="Par15">Targeted Sequencing (TS) and Whole Exome Sequencing (WES) was performed as described elsewhere (refs <xref ref-type="bibr" rid="CR33">33</xref> and <xref ref-type="bibr" rid="CR4">4</xref> respectively). All UK10K WES samples from all arms of the exome study available at the time of the variant calling and SCOOP TS samples (N = 5,233 and 2,819 respectively) were called together on the non-redundant targets + /− 100 bp using multi-sample calling. Using SAMtools<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, a BCF file was created and the site genotype likelihoods were calculated. Variants (SNPs and Indels) were called using BCFtools. Indels were left-aligned using ‘vcf norm’ from the htslib package. Variants were filtered for sequencing and genotype quality at the site and genotype level using <italic>vcf-annotate</italic>
<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Additional details in Supplementary Note <xref ref-type="media" rid="MOESM2">2</xref>.</p>
</sec>
<sec id="Sec10">
<title>Variant Annotation</title>
<p id="Par16">All variant annotation was applied using the GRCh37 human reference. Variants were annotated with rsIDs from dbSNP 137, and allele frequencies from the final 1000Genomes Phase 1 integrated (v3) callset<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, the NHLBI Exome Sequencing Project (ESP) v2<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, and the UK10K WGS sample set<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. The Ensembl Variant Effect Predictor (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/info/docs/variation/vep/index.html">http://www.ensembl.org/info/docs/variation/vep/index.html</ext-link>)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> v2.8 with Ensembl 66 was used to add variant consequence annotations including the predicted deleteriousness of each missense variant as predicted by SIFT<sup><xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref></sup>, PolyPhen<sup><xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref></sup>, and Condel<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. For the 32 known human obesity genes, only the variant consequences on the most clinically relevant transcript were considered for further analysis. For the other 87 candidate obesity genes, the most severe consequence on any transcript was retained for each variant (Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>). Using Sequence Ontology terms<sup><xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref></sup>, variant consequences were defined as functional (i.e. essential splice site, stop gained, stop lost, complex indel, frameshift coding, non synonymous coding, within mature miRNA, partial codon).</p>
<p id="Par17">To identify <bold><italic>rare</italic></bold> variants, we used the thirteen UK10K WES sample sets that were not obese sample sets and were not included as controls in this study (Supplementary Note <xref ref-type="media" rid="MOESM2">1</xref>). These sample sets were processed in parallel with our cases and controls and thus provide a similar sequencing coverage and depth across the called regions. We removed variants that had a MAF &gt; 1% across all or a MAF &gt; 10% in any of the thirteen sample sets. We then removed variants with a MAF &gt; 1% in any of seven additional sample sets: 1. UK10K WGS sample set<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, 2–3. European and African American NHLBI ESP v2 sample sets <sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, and 4–7, the four continent sample sets (AFR, AMR, ASN, EUR) from 1000 Genomes Phase 1 integrated v3 call set<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. <bold><italic>Novel</italic></bold> variants were identified as sites not seen in any of the internal or external datasets used for MAF annotation, i.e. novel at the time of this study.</p>
</sec>
<sec id="Sec11">
<title>Sample quality control</title>
<p id="Par18">Samples were identified as contaminated using a combination of two methods: VerifyBamID v1.0<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> and “fraction skewed hets”<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. For the TS samples, the FREEMIX value was estimated using 11,250 high quality, autosomal, biallelic SNPs with an alternate AF ≥ 0.01, and a call rate ≥ 0.5 in both the TS sample set and the 1000Genomes Project Phase 1 v3<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Of the 2,819 TS SCOOP samples, the 784 WES SCOOP samples, and the 1427 WES samples used as controls 37, one, and nine were excluded due to contamination respectively. Sixteen non-contaminated TS samples were excluded based on a mean sample read-depth 3 SD below the average for all samples (i.e. mean sample read-depth &lt; 12.09). Genotype concordance for 436 WES SCOOP samples and 1,035 TS SCOOP samples for which we had both sequence and GWAS data<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> was also calculated. Four WES samples and six TS samples with a concordance rate below 90% were identified and excluded. A set of highly polymorphic markers (MAF &gt; 0.3) was genotyped and compared to the sequencing calls from each sample. Non-concordant WES samples were removed prior to variant calling and are not included in the original sequencing numbers. Eighty-one TS samples with low concordance were removed after variant calling. Three TS samples were removed due to having an extremely high genotype missing rate of &gt; 50%.</p>
<p id="Par19">To identify non-European samples, we calculated principal components (PCs) from the 1000Genomes Phase I integrated call set<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> using either EIGENSTRAT v4.2<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> or LASER 2.0<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> for the WES and TS samples respectively (Supplementary Note <xref ref-type="media" rid="MOESM2">3</xref>). Of the 2,676 TS samples, 837 were classified as non-European due to genetic ancestry and three were excluded due to a reported non-European ancestry resulting in 1,836 good quality TS samples of European ancestry. Of the 779 WES SCOOP samples, 37 samples were classified as non-European due to genetic ancestry resulting in 742 good quality WES SCOOP samples of European ancestry. Of the 1,418 control samples, 146 were identified as being non-European leaving 1272 high quality WES controls.</p>
<p id="Par20">Known and cryptic relatedness was identified by estimating pairwise identity by descent using PLINK v1.07<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Genetic relationships within the WES sample set is described in detail elsewhere<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. We removed individuals sequentially by: (1) largest number of relationships, (2) diseased controls, non-diseased controls, cases, (3) lower mean depth of sequencing. Five SCOOP cases and 155 controls were removed resulting in 737 SCOOP WES cases and 1,117 WES controls all of high quality, unrelated, and European ancestry. A similar process was used to identify genetic relationships within the TS sample set and between the TS and WES sample sets (Supplementary Note <xref ref-type="media" rid="MOESM2">3</xref>). This resulted in 25 additional exclusions (18 TS cases related to WES cases and seven related within the TS sample set) for a total of 1,811 high quality, unrelated, TS samples of European ancestry.</p>
</sec>
<sec id="Sec12">
<title>Candidate Gene Sets</title>
<p id="Par21">We performed database searches using keywords ‘obesity’, ‘growth’, ‘size’, ‘adipose tissue’, (details below) and manually curated the results to arrive at a set of six tiers of candidate gene with definite or likely links to obesity. The Online Mendelian Inheritance of Man (OMIM database, <ext-link ext-link-type="uri" xlink:href="http://www.omim.org/">http://www.omim.org/</ext-link>) accessed in February, 2013<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> was used to identify 32 genes (Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>) which directly lead to human obesity. These were further categorised into two groups based on consistent clinical features: genes characterised by “Obesity alone” (<italic>Obesity Alone</italic>; n = 6), and “Obesity and developmental delay and/or dysmorphology” (<italic>Obesity and Delay;</italic> n = 26). Any putative list of candidate genes has limitations and other genes that contribute to energy homeostasis/obesity in animal models deserve interrogation in the future.</p>
<p id="Par22">Genes that cause obesity when disrupted in rodents were identified using the Mouse Genome Informatics Database (MGI, <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/">http://www.informatics.jax.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> and the Rat Genome Database (RGD, <ext-link ext-link-type="uri" xlink:href="http://rgd.mcw.edu">http://rgd.mcw.edu</ext-link>)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> both accessed in February 2013, as well as published research (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.gov/Pubmed">www.ncbi.nlm.gov/Pubmed</ext-link>). Eighty-seven genes were associated with a growth/size phenotype when perturbed in rodent animal models. We evaluated the strength of evidence for a role of each gene in obesity phenotype and divided them into four further categories, specifically: Loss of function associated with obesity in mice (<italic>LoF Mice</italic>; n = 51); gain of function associated with obesity in mice (<italic>GoF Mice</italic>, n = 5); anorectic peptides and receptors (<italic>Anorectic Molecules</italic>, n = 7); loss of function associated with other metabolic phenotypes in mice (<italic>Complex Metabolic Effects</italic>, n = 24) (Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>).</p>
</sec>
<sec id="Sec13">
<title>Sequence validation of rare functional variants</title>
<p id="Par23">Novel, functional variants in all 119 candidate genes were taken forward for validation by conventional Sanger sequencing (90% validation rate). Briefly, customized PCR primers were designed+/−250 bp surrounding the variant; and sequencing was performed using BigDye Terminator v3 kit (Applied BioSystems) and analysed by capillary electrophoresis on an ABI3730 DNA Analyzer platform (Applied Biosystems), according to the manufacturers’ instructions. Familial segregation analysis of variants was performed where family samples were available.</p>
</sec>
<sec id="Sec14">
<title>Identification of clinically-associated variants in known human obesity genes</title>
<p id="Par24">The strategy for identification of clinically-associated variants in known human obesity genes is outlined in Fig. <xref ref-type="fig" rid="Fig1">1</xref>. Briefly, novel and rare variants in the known human obesity genes were filtered using the ClinVar database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/">http://www.ncbi.nlm.nih.gov/clinvar/</ext-link>). We retained novel variants and those with a ClinVar status of Pathogenic/Likely pathogenic (N = 332).</p>
</sec>
<sec id="Sec15">
<title>Structural Analysis of GNAS Variants</title>
<p id="Par25">For structural analysis of the genetic variants and prediction of their impact on protein function, we modelled their location in relation to previously solved protein crystal structures of GNAS in complex with either G-protein coupled receptor (ADRB2) or downstream effector (adenylyl cyclase). Specifically, the first model represented in Fig. <xref ref-type="fig" rid="Fig3">3a</xref> is based on crystal structure of the active state ternary protein complex of GPCR beta-2-adrenergic receptor (ADRB2), and the nucleotide-free Gs heterotrimer, composed of Gs-α(GNAS), Gs-β, and Gs-γ subunits (ref. <xref ref-type="bibr" rid="CR20">20</xref>, PDB number: 3SN6, <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>). The second model, represented in Fig. <xref ref-type="fig" rid="Fig3">3b</xref>, is based on complex of GNAS with the catalytic domains of mammalian adenylyl cyclase (ref. <xref ref-type="bibr" rid="CR21">21</xref>, PDB number: 1AZS, <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>). The structural representations using ribbon-depicted models were generated using the Open-Source PyMOL Molecular Graphics System, Version 1.7.x Schrödinger, LLC (<ext-link ext-link-type="uri" xlink:href="http://pymol.org">http://pymol.org</ext-link>).</p>
</sec>
<sec id="Sec16">
<title>Association Analyses</title>
<p id="Par26">We implemented the optimal Sequence Kernel Association Test SKAT-O<sup><xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR53">53</xref></sup> with the SKAT R package v1.1.2<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> using options <italic>method</italic> = ”optimal.adj” for SKAT-O and <italic>r.corr</italic> = <italic>1</italic> for burden. For each gene and candidate gene set, we performed two primary tests using the burden test: 1. rare functional (<italic>Rare Func</italic>) or (2) novel functional (<italic>Novel Func</italic>). We performed secondary tests restricting either to variants that were predicted to be deleterious by at least one of the three algorithms (i.e. SIFT, PolyPhen, and Condel) (<italic>1</italic> + <italic>del</italic>) or to variants that were predicted to be deleterious by all three algorithms (<italic>all del</italic>). For SIFT and Condel, variants were classified as deleterious if they were labelled as “deleterious”. For PolyPhen, variants were classified as deleterious if they were labelled as “probably damaging” or “damaging”. Our conservative Bonferroni adjusted significance level of the primary analyses for 119 genes and 6 gene sets was 0.05/(2 × 125) = 2.0E-4. Once considering our additional ten secondary tests, our Bonferroni adjusted significance level was 0.05/(12 × 125) = 3.3E-5. We repeated all primary and secondary tests using SKAT-O <bold>(</bold>Table <xref ref-type="table" rid="Tab1">1</xref>
<bold>;</bold> Supplementary Table <xref ref-type="media" rid="MOESM1">4</xref>–<xref ref-type="media" rid="MOESM1">9</xref>, <xref ref-type="media" rid="MOESM1">13</xref>).</p>
</sec>
<sec id="Sec17">
<title>Functional studies of variants in ANGPTL6</title>
<p id="Par27">To predict the impact of variants on the ANGPTL6 protein, we modelled their location using the crystal structure of a related protein fibrinogen in a complex with a peptide Gly-His-Pro-amide (described in Yang <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>, PDB number: 1LWU, <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>). The structural representations using ribbon-depicted models were generated using the Open-Source PyMOL Molecular Graphics System, Version 1.7.x Schrödinger, LLC (<ext-link ext-link-type="uri" xlink:href="http://pymol.org">http://pymol.org</ext-link>). N-terminal triple Flag tag was added to human <italic>ANGPTL6</italic> cDNA cloned into a pEZ-M14 mammalian expression vector (Capital Bioscience). Mutations were introduced into this construct using QuikChange (Agilent technologies), and confirmed by Sanger sequencing. ANGPTL6 protein expression was studied by transient transfection in HEK293 cells. Media was collected 48 h – post transfection, the cell medium was centrifuged for 5 min (5,000 g at 4 °C) and the supernatants were collected. Cells were harvested prior to centrifugation for 15 min (15,000 g at 4 °C). Aliquots from the medium and cells were subjected to SDS-PAGE and immunoblot analysis. Primary antibodies (monoclonal Flag M2 antibody (Sigma) and a polyclonal antibody to Calnexin (Cell signalling)) were used at 1:1000, and secondary Horseradish peroxidase–conjugated anti-mouse or anti-rabbit IgG (Dako) antibody at 1:2000 dilution. After staining with ECL West Dura Substrate kit (Thermo Scientific), visualisation was performed on Chemidoc Digital Imager (Bio-Rad) (Supplementary Information). The relative protein secretion of ANGPTL6 for each variant was standardized to wild-type protein secretion. Experiments were performed in triplicate and analysed using an unpaired T-test with Welch’s correction.</p>
</sec>
<sec id="Sec18">
<title>ANGPTL6 statistical follow-up analyses</title>
<p id="Par28">We ran gene-based analyses using SKAT-O as described above on two subsets of ANGPTL6 variants (Supplementary Table <xref ref-type="media" rid="MOESM1">10</xref>): (1) the one variant that resulted in a complete loss of protein secretion (S284X; rs201622589), and (2) excluding S284X. For (1), we also used a Fisher’s Exact Test. We repeated the Fisher’s Exact Test of the S284X variant including additional population controls with pre-existing genotype data and replication samples (Online Methods, <underline>Sample Sets</underline>; Supplementary Tables <xref ref-type="media" rid="MOESM1">11</xref> and <xref ref-type="media" rid="MOESM1">12</xref>).</p>
</sec>
<sec id="Sec19">
<title>Power Analysis</title>
<p id="Par29">We calculated the power to detect association to a gene region using the burden test with the <italic>Power_Logistic_R</italic> function and the haplotype dataset within the SKAT R-package<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. We performed power calculations using 500 simulations on a random 2Kb sub region. The effect sizes of the causal variants are equal to log<sub>10</sub>(MAF) with a maximum effect size of 1.6 (MAF = 0.0001) and all have the same direction of effect. We limited the MAF threshold for causal variants to ≤ 0.01, 0.001, 0.0005 and varied the percentage of causal variants in the region to be between 10–90%. (More details in Supplementary Note <xref ref-type="media" rid="MOESM2">4</xref>).</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec24">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_3054_MOESM1_ESM.xlsx"><caption><p>Supplementary Tables</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41598_2017_3054_MOESM2_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Audrey E. Hendricks and Elena G. Bochukova contributed equally to this work.</p>
</fn>
<fn>
<p>A comprehensive list of consortium members appears at the end of the paper.</p>
</fn>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>
<bold>Supplementary information</bold> accompanies this paper at doi:10.1038/s41598-017-03054-8
</p>
</fn>
<fn>
<p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We are indebted to the patients and their families for their participation and to the physicians involved in the Genetics of Obesity Study (GOOS). This work was supported by the Wellcome Trust (ISF, IB) (098497/Z/12/Z; WT098051), Medical Research Council (ISF, SOR) (MRC_MC_UU_12012/5), NIHR Cambridge Biomedical Research Centre (ISF, IB, SOR), Bernard Wolfe Health Neuroscience Endowment (ISF), European Research Council (ISF) and NIH grant DK064265 (GLM), the European Community’s Seventh Framework Programme (FP7/2007–2013) project Beta-JUDO n°279153 (ISF, AK). This study comprises one arm of the UK10K Consortium (WT091310). The UK Household Longitudinal Study is led by the Institute for Social and Economic Research at the University of Essex and funded by the Economic and Social Research Council. The survey was conducted by NatCen and the genome-wide scan data were analysed and deposited by the Wellcome Trust Sanger Institute. Information on how to access the data can be found on the Understanding Society website <ext-link ext-link-type="uri" xlink:href="https://www.understandingsociety.ac.uk/">https://www.understandingsociety.ac.uk/</ext-link>. AH and JH were funded by the German Ministry for Education and Research (National Genome Research Net-Plus 01GS0820), the German Research Foundation (DFG; HI865/2-1), the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreements n°245009 and n°262055. We thank participants and staff of the Copenhagen City Heart Study, Copenhagen Ischemic Heart Disease Study, and the Copenhagen General Population Study for their important contributions (CCHS, CGPS, CIHDS). CHD case ascertainment and validation, genotyping, and clinical chemistry assays in EPIC-CVD were supported by grants awarded to the University of Cambridge from the EU Framework Programme 7 (HEALTH-F2-2012-279233), the UK Medical Research Council (G0800270) and British Heart Foundation (SP/09/002), the European Research Council (268834), the UK National Institute for Health Research Cambridge Biomedical Research Centre, Merck and Pfizer. We thank all EPIC participants and staff for their contribution to the study, the laboratory teams at the Medical Research Council Epidemiology Unit for sample management and Cambridge Genomic Services for genotyping, Sarah Spackman for data management, and the team at the EPIC-CVD Coordinating Centre for study coordination and administration (EPIC-CVD). JD is supported by a British Heart Foundation Professorship, NIHR Senior Investigator, European Research Council Senior Investigator. Leipzig LIFE Child as part of the Leipzig Childhood Obesity cohort was funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative. This research has been conducted using the UK Biobank Resource.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author Contributions</title>
<p>I.B., I.S.F., A.E. and E.G.B. designed the study, analysed the data and wrote the paper. J.M.K., R.B., S.A., E.H. contributed to recruitment and consenting of the cohort; N.A., V.M., A.K., S.P., S.G. to validation of genetic findings in family studies and functional studies; G.M., E.W., I.T., E.Z. contributed to data analysis and G.L.M., R.I.P., S.O.R., to data collection and/or analysis. A.K., J.K. contributed data in Leipzig children. A.H., J.H., R.A.S., C.L., N.J.W., P.S., J.M.M.H., A.S.B., J.D., B.G.N., S.F.N., S.A., Understanding Society Scientific Group, EPIC-CVD Consortium contributed data for the <italic>ANGPTL6</italic> (p.S284X) variant. Targeted and whole-exome sequencing was performed as part of the UK10K consortium. All authors reviewed and contributed to the final version of the paper.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing Interests</title>
<p id="Par30">The authors declare that they have no competing interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Sayed Moustafa</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Froguel</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>From obesity genetics to the future of personalized obesity therapy</article-title>
<source/>Nat Rev Endocrinol
          <year>2013</year>
<volume>9</volume>
<fpage>402</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1038/nrendo.2013.57</pub-id>
<pub-id pub-id-type="pmid">23529041</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Klaauw</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</name>
</person-group>
<article-title>The hunger genes: pathways to obesity</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>119</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.03.008</pub-id>
<pub-id pub-id-type="pmid">25815990</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<fpage>513</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2607</pub-id>
<pub-id pub-id-type="pmid">23563609</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consortium</surname>
<given-names>UK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The UK10K project identifies rare variants in health and disease</article-title>
<source/>Nature
          <year>2015</year>
<volume>526</volume>
<fpage>82</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1038/nature14962</pub-id>
<pub-id pub-id-type="pmid">26367797</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene</article-title>
<source/>N Engl J Med
          <year>2003</year>
<volume>348</volume>
<fpage>1085</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa022050</pub-id>
<pub-id pub-id-type="pmid">12646665</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemos</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Thakker</surname>
<given-names>RV</given-names>
</name>
</person-group>
<article-title>GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders</article-title>
<source/>Hum Mutat
          <year>2015</year>
<volume>36</volume>
<fpage>11</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22696</pub-id>
<pub-id pub-id-type="pmid">25219572</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldred</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Trembath</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Activating and inactivating mutations in the human GNAS1 gene</article-title>
<source/>Hum Mutat
          <year>2000</year>
<volume>16</volume>
<fpage>183</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/1098-1004(200009)16:3&lt;183::AID-HUMU1&gt;3.0.CO;2-L</pub-id>
<pub-id pub-id-type="pmid">10980525</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warner</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matalon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation</article-title>
<source/>J Biol Chem
          <year>1998</year>
<volume>273</volume>
<fpage>23976</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.37.23976</pub-id>
<pub-id pub-id-type="pmid">9727013</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastida Eizaguirre</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>[Albright hereditary osteodystrophy: identification of a novel mutation in a family]</article-title>
<source/>An Esp Pediatr
          <year>2001</year>
<volume>54</volume>
<fpage>598</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="doi">10.1016/S1695-4033(01)77602-3</pub-id>
<pub-id pub-id-type="pmid">11412411</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation</article-title>
<source/>Cell Metab
          <year>2009</year>
<volume>9</volume>
<fpage>548</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2009.05.004</pub-id>
<pub-id pub-id-type="pmid">19490909</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Optimal tests for rare variant effects in sequencing association studies</article-title>
<source/>Biostatistics
          <year>2012</year>
<volume>13</volume>
<fpage>762</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1093/biostatistics/kxs014</pub-id>
<pub-id pub-id-type="pmid">22699862</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moutsianas</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease</article-title>
<source/>PLoS Genet
          <year>2015</year>
<volume>11</volume>
<fpage>e1005165</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005165</pub-id>
<pub-id pub-id-type="pmid">25906071</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oike</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Angiopoietin-related growth factor antagonizes obesity and insulin resistance</article-title>
<source/>Nat Med
          <year>2005</year>
<volume>11</volume>
<fpage>400</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/nm1214</pub-id>
<pub-id pub-id-type="pmid">15778720</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadomatsu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oike</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases</article-title>
<source/>FEBS J
          <year>2011</year>
<volume>278</volume>
<fpage>559</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07979.x</pub-id>
<pub-id pub-id-type="pmid">21182596</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A polygenic burden of rare disruptive mutations in schizophrenia</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>185</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1038/nature12975</pub-id>
<pub-id pub-id-type="pmid">24463508</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Convergence of genes and cellular pathways dysregulated in autism spectrum disorders</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>94</volume>
<fpage>677</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.018</pub-id>
<pub-id pub-id-type="pmid">24768552</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excess of rare, inherited truncating mutations in autism</article-title>
<source/>Nat Genet
          <year>2015</year>
<volume>47</volume>
<fpage>582</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3303</pub-id>
<pub-id pub-id-type="pmid">25961944</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of recombinant leptin therapy in a child with congenital leptin deficiency</article-title>
<source/>N Engl J Med
          <year>1999</year>
<volume>341</volume>
<fpage>879</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199909163411204</pub-id>
<pub-id pub-id-type="pmid">10486419</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuhnen</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>375</volume>
<fpage>240</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1512693</pub-id>
<pub-id pub-id-type="pmid">27468060</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>SG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Crystal structure of the beta2 adrenergic receptor-Gs protein complex</article-title>
<source/>Nature
          <year>2011</year>
<volume>477</volume>
<fpage>549</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1038/nature10361</pub-id>
<pub-id pub-id-type="pmid">21772288</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tesmer</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sunahara</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Gilman</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Sprang</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS</article-title>
<source/>Science
          <year>1997</year>
<volume>278</volume>
<fpage>1907</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1126/science.278.5345.1907</pub-id>
<pub-id pub-id-type="pmid">9417641</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<mixed-citation publication-type="other">Lynn, P. Sample design for Understanding Society. <italic>Understanding Society Working Paper Series</italic><bold>2009–01</bold>(2009).</mixed-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Day</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer</article-title>
<source/>Br J Cancer
          <year>1999</year>
<volume>80</volume>
<issue>Suppl 1</issue>
<fpage>95</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">10466767</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamstrup</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Tybjaerg-Hansen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steffensen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nordestgaard</surname>
<given-names>BG</given-names>
</name>
</person-group>
<article-title>Genetically elevated lipoprotein(a) and increased risk of myocardial infarction</article-title>
<source/>JAMA
          <year>2009</year>
<volume>301</volume>
<fpage>2331</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2009.801</pub-id>
<pub-id pub-id-type="pmid">19509380</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordestgaard</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Benn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schnohr</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tybjaerg-Hansen</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women</article-title>
<source/>JAMA
          <year>2007</year>
<volume>298</volume>
<fpage>299</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1001/jama.298.3.299</pub-id>
<pub-id pub-id-type="pmid">17635890</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varbo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Remnant cholesterol as a causal risk factor for ischemic heart disease</article-title>
<source/>J Am Coll Cardiol
          <year>2013</year>
<volume>61</volume>
<fpage>427</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2012.08.1026</pub-id>
<pub-id pub-id-type="pmid">23265341</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danesh</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries</article-title>
<source/>Eur J Epidemiol
          <year>2007</year>
<volume>22</volume>
<fpage>129</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1007/s10654-006-9096-8</pub-id>
<pub-id pub-id-type="pmid">17295097</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudlow</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title>
<source/>PLoS Med
          <year>2015</year>
<volume>12</volume>
<fpage>e1001779</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id>
<pub-id pub-id-type="pmid">25826379</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<mixed-citation publication-type="other">Exome Aggregation Consortium (ExAC), Cambridge, MA <italic>(URL:</italic> http://exac.broadinstitute.org<italic>)</italic> ([September, 2015]).</mixed-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinney</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants</article-title>
<source/>PLoS ONE
          <year>2007</year>
<volume>2</volume>
<fpage>e1361</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0001361</pub-id>
<pub-id pub-id-type="pmid">18159244</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quante</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The LIFE child study: a life course approach to disease and health</article-title>
<source/>BMC Public Health
          <year>2012</year>
<volume>12</volume>
<fpage>1021</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2458-12-1021</pub-id>
<pub-id pub-id-type="pmid">23181778</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berndt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stumvoll</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kiess</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children</article-title>
<source/>J Clin Endocrinol Metab
          <year>2007</year>
<volume>92</volume>
<fpage>1956</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2006-2514</pub-id>
<pub-id pub-id-type="pmid">17311858</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>94</volume>
<fpage>618</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.006</pub-id>
<pub-id pub-id-type="pmid">24680889</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<fpage>2078</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danecek</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The variant call format and VCFtools</article-title>
<source/>Bioinformatics
          <year>2011</year>
<volume>27</volume>
<fpage>2156</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr330</pub-id>
<pub-id pub-id-type="pmid">21653522</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genomes Project</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A map of human genome variation from population-scale sequencing</article-title>
<source/>Nature
          <year>2010</year>
<volume>467</volume>
<fpage>1061</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1038/nature09534</pub-id>
<pub-id pub-id-type="pmid">20981092</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tennessen</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evolution and functional impact of rare coding variation from deep sequencing of human exomes</article-title>
<source/>Science
          <year>2012</year>
<volume>337</volume>
<fpage>64</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1126/science.1219240</pub-id>
<pub-id pub-id-type="pmid">22604720</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLaren</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor</article-title>
<source/>Bioinformatics
          <year>2010</year>
<volume>26</volume>
<fpage>2069</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btq330</pub-id>
<pub-id pub-id-type="pmid">20562413</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
<source/>Nucleic Acids Res
          <year>2003</year>
<volume>31</volume>
<fpage>3812</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>
<pub-id pub-id-type="pmid">12824425</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Predicting the effects of amino acid substitutions on protein function</article-title>
<source/>Annu Rev Genomics Hum Genet
          <year>2006</year>
<volume>7</volume>
<fpage>61</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.genom.7.080505.115630</pub-id>
<pub-id pub-id-type="pmid">16824020</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sunyaev</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ramensky</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Towards a structural basis of human non-synonymous single nucleotide polymorphisms</article-title>
<source/>Trends Genet
          <year>2000</year>
<volume>16</volume>
<fpage>198</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1016/S0168-9525(00)01988-0</pub-id>
<pub-id pub-id-type="pmid">10782110</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sunyaev</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prediction of deleterious human alleles</article-title>
<source/>Hum Mol Genet
          <year>2001</year>
<volume>10</volume>
<fpage>591</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.6.591</pub-id>
<pub-id pub-id-type="pmid">11230178</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Perez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lopez-Bigas</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>88</volume>
<fpage>440</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.03.004</pub-id>
<pub-id pub-id-type="pmid">21457909</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eilbeck</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Sequence Ontology: a tool for the unification of genome annotations</article-title>
<source/>Genome Biol
          <year>2005</year>
<volume>6</volume>
<fpage>R44</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2005-6-5-r44</pub-id>
<pub-id pub-id-type="pmid">15892872</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mungall</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Batchelor</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Eilbeck</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Evolution of the Sequence Ontology terms and relationships</article-title>
<source/>J Biomed Inform
          <year>2011</year>
<volume>44</volume>
<fpage>87</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbi.2010.03.002</pub-id>
<pub-id pub-id-type="pmid">20226267</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jun</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data</article-title>
<source/>Am J Hum Genet
          <year>2012</year>
<volume>91</volume>
<fpage>839</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.09.004</pub-id>
<pub-id pub-id-type="pmid">23103226</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>
<source/>Nat Genet
          <year>2006</year>
<volume>38</volume>
<fpage>904</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/ng1847</pub-id>
<pub-id pub-id-type="pmid">16862161</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Improved ancestry estimation for both genotyping and sequencing data using projection procrustes analysis and genotype imputation</article-title>
<source/>Am J Hum Genet
          <year>2015</year>
<volume>96</volume>
<fpage>926</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.04.018</pub-id>
<pub-id pub-id-type="pmid">26027497</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<fpage>559</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<mixed-citation publication-type="other">Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), (http://omim.org/) (February, 2013).</mixed-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<mixed-citation publication-type="other">The Mouse Genome Database (MGD), Mouse Genome Informatics. <italic>The Jackson Laboratory, Bar Harbor, Maine</italic>. http://www.informatics.jax.org (February, 2013).</mixed-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<mixed-citation publication-type="other">The Rat Genome Browser (RGD), Rat Genome Database Web Site. <italic>Medical College of Wisconsin, Milwaukee, Wisconsin</italic> http://rgd.mcw.edu/ (February, 2013).</mixed-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare-variant association testing for sequencing data with the sequence kernel association test</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>89</volume>
<fpage>82</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.05.029</pub-id>
<pub-id pub-id-type="pmid">21737059</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<mixed-citation publication-type="other">Seunggeun Lee, with contributions from Larisa Miropolsky and Michael Wu. SKAT: SNP-Set(Sequence) Kernel Association Test.. <italic>R package version 1.1.2</italic>. http://CRAN.R-project.org/package=SKAT (2015).</mixed-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide</article-title>
<source/>Biochemistry
          <year>2002</year>
<volume>41</volume>
<fpage>10218</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1021/bi020299t</pub-id>
<pub-id pub-id-type="pmid">12162736</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>